| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | HNF1A PCGF2 CHD1 POU4F2 RUNX2 MED1 GMNN IKZF5 PRDM1 NCOR2 SETDB1 SALL1 NFATC3 TP63 KMT2A VAX2 ATF4 POLQ OBI1 CRTC2 PROP1 | 1.97e-06 | 739 | 174 | 21 | GO:0003682 |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 2.58e-06 | 4 | 174 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 8.04e-06 | 83 | 174 | 7 | GO:1990841 | |
| GeneOntologyMolecularFunction | transcription factor binding | HNF1A RARB SALL4 RUNX2 MED1 RUNX1T1 SIX3 RUNX3 GMNN NCOR2 SALL1 NFATC3 CD34 EHMT1 KMT2A TBXT ATF4 PRKDC HTT CRTC2 | 9.58e-06 | 753 | 174 | 20 | GO:0008134 |
| GeneOntologyMolecularFunction | protein domain specific binding | DTNA RUNX2 MED1 IKZF5 ZNF106 KIDINS220 DLC1 MAVS MUC17 ZNF592 TP63 EHMT1 IRS2 ATF4 PRKDC RAPGEF2 SRRM2 ATP2B1 ATP2B2 ATP2B3 | 7.99e-05 | 875 | 174 | 20 | GO:0019904 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.02e-04 | 11 | 174 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.03e-04 | 123 | 174 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TBX15 HNF1A RARB SALL4 POU4F2 POU4F3 SIX4 RUNX2 MED1 SIX3 RUNX3 BATF2 IKZF5 PRDM1 TBX19 SALL1 NFATC3 TP63 CARF VAX2 TBXT ATF4 SMAD1 PROP1 | 2.08e-04 | 1244 | 174 | 24 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TBX15 HNF1A RARB SALL4 POU4F2 POU4F3 SIX4 RUNX2 MED1 SIX3 RUNX3 BATF2 IKZF5 PRDM1 TBX19 SALL1 NFATC3 TP63 CARF VAX2 TBXT ATF4 SMAD1 PROP1 | 2.85e-04 | 1271 | 174 | 24 | GO:0000987 |
| GeneOntologyMolecularFunction | protein serine kinase activity | MAST2 WNK1 MAP3K1 PASK MAST4 MAST1 PRKDC MAP3K13 ULK1 WNK2 MAST3 | 3.54e-04 | 363 | 174 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | HJV MAST2 WNK1 MAP3K1 PASK MAST4 MAST1 PRKDC MAP3K13 ULK1 WNK2 MAST3 | 5.58e-04 | 446 | 174 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 5.76e-04 | 44 | 174 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | HNF1A POU4F2 POU4F3 SIX4 RUNX2 SIX3 TBX19 NFATC3 TP63 CARF ATF4 SMAD1 PROP1 | 1.29e-03 | 560 | 174 | 13 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | HNF1A POU4F2 POU4F3 SIX4 RUNX2 SIX3 TBX19 NFATC3 TP63 CARF ATF4 SMAD1 PROP1 | 1.42e-03 | 566 | 174 | 13 | GO:0001216 |
| GeneOntologyBiologicalProcess | embryo development | TBX15 TANC2 HNF1A PCGF2 RARB AMBRA1 SALL4 POU4F3 EYA1 SIX4 RUNX2 MED1 SIX3 MFRP WNK1 INO80D PRDM1 TBX19 NCOR2 SETDB1 KIDINS220 SALL1 DLC1 AMOT TP63 SEC24B EHMT1 KMT2A VAX2 TBXT ATF4 PRKDC ATP2B2 SMAD1 HTT | 8.95e-09 | 1437 | 173 | 35 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | TBX15 HNF1A PCGF2 RARB SALL4 POU4F3 EYA1 SIX4 RUNX2 MED1 SIX3 WNK1 TBX19 SALL1 DLC1 AMOT TP63 SEC24B VAX2 TBXT ATP2B2 SMAD1 HTT | 3.27e-08 | 713 | 173 | 23 | GO:0048598 |
| GeneOntologyBiologicalProcess | brain development | RARB HTR5A HTR6 SZT2 MED1 SIX3 TBX19 NCOR2 SALL1 DLC1 MACO1 SEC24B MAST1 VAX2 IRS2 PRKDC ULK1 RAPGEF2 ATP2B2 TRAPPC9 SMAD1 HTT PROP1 AMIGO2 | 2.32e-07 | 859 | 173 | 24 | GO:0007420 |
| GeneOntologyBiologicalProcess | head development | RARB HTR5A HTR6 SZT2 MED1 SIX3 TBX19 NCOR2 SALL1 DLC1 MACO1 SEC24B MAST1 VAX2 IRS2 PRKDC ULK1 RAPGEF2 ATP2B2 TRAPPC9 SMAD1 HTT PROP1 AMIGO2 | 7.81e-07 | 919 | 173 | 24 | GO:0060322 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TBX15 HNF1A PCGF2 RARB KIF26B POU4F3 EYA1 SIX4 RUNX2 MED1 SIX3 MFRP GMNN PRDM1 TBX19 NCOR2 SALL1 DLC1 TP63 CD34 SEC24B VAX2 TBXT ATF4 CSMD1 ATP2B2 HTT PROP1 | 2.44e-06 | 1269 | 173 | 28 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryonic organ development | TBX15 PCGF2 RARB POU4F3 EYA1 SIX4 RUNX2 MED1 SIX3 PRDM1 SALL1 SEC24B KMT2A VAX2 TBXT ATF4 ATP2B2 | 5.28e-06 | 561 | 173 | 17 | GO:0048568 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | TBX15 TANC2 HNF1A PCGF2 AMBRA1 SALL4 EYA1 SIX4 RUNX2 MED1 MFRP PRDM1 NCOR2 SETDB1 KIDINS220 SALL1 DLC1 AMOT SEC24B TBXT PRKDC HTT | 1.11e-05 | 929 | 173 | 22 | GO:0009792 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | HNF1A KIF26B SALL4 EYA1 SIX4 MED1 SIX3 RUNX3 MAP3K1 TBX19 SALL1 DLC1 NFATC3 TP63 SEC24B TBXT CSMD1 SMAD1 HTT | 1.85e-05 | 750 | 173 | 19 | GO:0048729 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 MAP1B SZT2 PPFIA2 ALS2 POU4F2 POU4F3 CORO1B MED1 RUNX3 MAP3K1 KANK1 KIDINS220 DLC1 CELSR3 SIPA1L1 SEC24B VAX2 ATF4 PRKDC MAP3K13 ULK1 RAPGEF2 MUC3A ATP2B2 | 2.19e-05 | 1194 | 173 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | chordate embryonic development | TBX15 TANC2 HNF1A PCGF2 AMBRA1 SALL4 EYA1 SIX4 RUNX2 MED1 PRDM1 NCOR2 SETDB1 KIDINS220 SALL1 DLC1 AMOT SEC24B TBXT PRKDC HTT | 2.46e-05 | 906 | 173 | 21 | GO:0043009 |
| GeneOntologyBiologicalProcess | ureteric bud elongation | 3.15e-05 | 8 | 173 | 3 | GO:0060677 | |
| GeneOntologyBiologicalProcess | epithelium development | RARB MAP1B KIF26B PUM2 AMBRA1 SALL4 POU4F3 EYA1 SIX4 MED1 SIX3 RUNX3 MAP3K1 PRDM1 NCOR2 SALL1 DLC1 NFATC3 TP63 SEC24B TBXT ATF4 PRKDC RAPGEF2 CSMD1 ATP2B2 SMAD1 HTT | 3.66e-05 | 1469 | 173 | 28 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | HTR6 MAP1B SYNPO PPFIA3 KCNB1 SIPA1L1 KMT2A ATF4 RAPGEF2 ATP2B2 HTT | 3.87e-05 | 293 | 173 | 11 | GO:0048167 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | HJV TBX15 RALGAPA1 HNF1A PCGF2 RARB SALL4 POU4F2 SIX4 RUNX2 MED1 RUNX1T1 SIX3 RUNX3 GMNN IKZF5 PRDM1 NCOR2 SETDB1 SALL1 NFATC3 TP63 EHMT1 VAX2 TBXT ATF4 PROP1 | 4.15e-05 | 1399 | 173 | 27 | GO:0045892 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | TBX15 PCGF2 RARB POU4F3 EYA1 SIX4 RUNX2 SIX3 SEC24B VAX2 TBXT ATP2B2 | 4.28e-05 | 351 | 173 | 12 | GO:0048562 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | TANC2 MAP1B PPFIA2 PUM2 POU4F2 CORO1B SIX4 RUNX2 WNK1 KANK1 SALL1 DLC1 NFATC3 AMOT CD34 DDHD1 SIPA1L1 SEC24B PRKDC MAP3K13 ULK1 RAPGEF2 SMAD1 | 4.28e-05 | 1090 | 173 | 23 | GO:0022603 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | HJV TBX15 RALGAPA1 HNF1A PCGF2 RARB SALL4 POU4F2 SIX4 RUNX2 MED1 RUNX1T1 SIX3 RUNX3 GMNN IKZF5 PRDM1 NCOR2 SETDB1 SALL1 NFATC3 TP63 EHMT1 VAX2 TBXT ATF4 PROP1 | 4.92e-05 | 1413 | 173 | 27 | GO:1902679 |
| GeneOntologyBiologicalProcess | mesoderm development | 5.51e-05 | 157 | 173 | 8 | GO:0007498 | |
| GeneOntologyBiologicalProcess | central nervous system development | RARB HTR5A HTR6 SZT2 MED1 SIX3 TBX19 NCOR2 SALL1 DLC1 MACO1 SEC24B MAST1 VAX2 IRS2 PRKDC ULK1 RAPGEF2 ATP2B2 TRAPPC9 SMAD1 HTT PROP1 AMIGO2 | 6.45e-05 | 1197 | 173 | 24 | GO:0007417 |
| GeneOntologyBiologicalProcess | mesoderm formation | 6.60e-05 | 82 | 173 | 6 | GO:0001707 | |
| GeneOntologyBiologicalProcess | forebrain development | RARB HTR5A HTR6 SZT2 SIX3 TBX19 NCOR2 SALL1 DLC1 VAX2 RAPGEF2 TRAPPC9 HTT PROP1 | 6.81e-05 | 489 | 173 | 14 | GO:0030900 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | HJV TBX15 RALGAPA1 HNF1A PCGF2 RARB SALL4 POU4F2 MED1 RUNX3 IKZF5 PRDM1 NCOR2 SETDB1 SALL1 NFATC3 TP63 EHMT1 VAX2 TBXT ATF4 PROP1 | 7.37e-05 | 1053 | 173 | 22 | GO:0000122 |
| GeneOntologyBiologicalProcess | mesoderm morphogenesis | 8.62e-05 | 86 | 173 | 6 | GO:0048332 | |
| GeneOntologyBiologicalProcess | neuron development | TANC2 MAP1B SZT2 PPFIA2 PUM2 ALS2 POU4F2 POU4F3 INPP5F RUNX3 MFRP WNK1 CSMD3 PRDM1 KANK1 KIDINS220 CELSR3 KCNB1 SIPA1L1 SEC24B VAX2 GRIP2 MAP3K13 ULK1 RAPGEF2 ATP2B2 HTT | 8.85e-05 | 1463 | 173 | 27 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 9.64e-05 | 29 | 173 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | HJV HNF1A RARB SALL4 POU4F2 POU4F3 EYA1 SIX4 RUNX2 MED1 SIX3 MAP3K1 TBX19 KMT2C SALL1 MAVS NFATC3 TP63 CARF KMT2A TBXT ATF4 PRKDC SMAD1 CRTC2 PROP1 | 9.78e-05 | 1390 | 173 | 26 | GO:0045944 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | RARB POU4F3 EYA1 SIX4 SIX3 MFRP PRDM1 SEC24B VAX2 ATF4 ATP2B2 | 1.57e-04 | 343 | 173 | 11 | GO:0090596 |
| GeneOntologyBiologicalProcess | dephosphorylation | PPM1E AMBRA1 TNS2 EYA1 INPP5F CTTNBP2NL DLC1 PIP4P2 TNS3 HTT SMG6 | 1.74e-04 | 347 | 173 | 11 | GO:0016311 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 MAP1B SZT2 PPFIA2 ALS2 POU4F2 POU4F3 RUNX3 KIDINS220 CELSR3 SIPA1L1 SEC24B VAX2 MAP3K13 ULK1 RAPGEF2 ATP2B2 | 1.92e-04 | 748 | 173 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 2.07e-04 | 190 | 173 | 8 | GO:0016331 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 MAP1B SZT2 PPFIA2 ALS2 POU4F2 POU4F3 CORO1B RUNX3 KANK1 KIDINS220 CELSR3 SIPA1L1 VAX2 MAP3K13 ULK1 RAPGEF2 MUC3A | 2.08e-04 | 826 | 173 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | negative regulation of lamellipodium morphogenesis | 2.09e-04 | 3 | 173 | 2 | GO:2000393 | |
| GeneOntologyBiologicalProcess | ureteric bud invasion | 2.09e-04 | 3 | 173 | 2 | GO:0072092 | |
| GeneOntologyBiologicalProcess | heart development | RARB ANK2 SALL4 POU4F2 EYA1 MED1 WNK1 PRDM1 TBX19 NCOR2 SALL1 DLC1 NFATC3 SEC24B TBXT PRKDC SMAD1 | 2.21e-04 | 757 | 173 | 17 | GO:0007507 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | MAP1B KIF26B PUM2 POU4F2 POU4F3 SIX4 MED1 SALL1 MAP3K13 ULK1 | 2.24e-04 | 299 | 173 | 10 | GO:0060560 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | KIF26B SALL4 EYA1 SIX4 MED1 RUNX3 MAP3K1 SALL1 DLC1 NFATC3 TP63 SEC24B TBXT CSMD1 HTT | 2.35e-04 | 619 | 173 | 15 | GO:0002009 |
| GeneOntologyBiologicalProcess | developmental growth | RARB MAP1B KIF26B PUM2 TNS2 SALL4 POU4F2 POU4F3 SIX4 MED1 SIX3 KMT2C SETDB1 SALL1 PRKDC MAP3K13 ULK1 IL6R SMAD1 | 2.41e-04 | 911 | 173 | 19 | GO:0048589 |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 2.56e-04 | 148 | 173 | 7 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 2.56e-04 | 148 | 173 | 7 | GO:0035113 | |
| GeneOntologyBiologicalProcess | sensory system development | RARB TTLL5 POU4F2 MED1 SIX3 MFRP MAP3K1 PRDM1 KMT2C VAX2 ATF4 ULK1 ATP2B2 | 2.67e-04 | 491 | 173 | 13 | GO:0048880 |
| GeneOntologyBiologicalProcess | ureteric bud development | 2.87e-04 | 107 | 173 | 6 | GO:0001657 | |
| GeneOntologyBiologicalProcess | positive regulation of mitophagy | 3.00e-04 | 16 | 173 | 3 | GO:1901526 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 3.33e-04 | 110 | 173 | 6 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 3.33e-04 | 110 | 173 | 6 | GO:0072163 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 3.40e-04 | 258 | 173 | 9 | GO:0001763 | |
| GeneOntologyBiologicalProcess | mesonephros development | 3.84e-04 | 113 | 173 | 6 | GO:0001823 | |
| GeneOntologyBiologicalProcess | negative regulation of mesoderm development | 4.15e-04 | 4 | 173 | 2 | GO:2000381 | |
| GeneOntologyBiologicalProcess | metanephric renal vesicle formation | 4.15e-04 | 4 | 173 | 2 | GO:0072093 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 4.20e-04 | 211 | 173 | 8 | GO:0060041 | |
| GeneOntologyBiologicalProcess | gastrulation | 4.33e-04 | 212 | 173 | 8 | GO:0007369 | |
| GeneOntologyBiologicalProcess | sensory organ development | RARB TTLL5 POU4F2 POU4F3 EYA1 SIX4 MED1 SIX3 MFRP MAP3K1 PRDM1 KMT2C SEC24B VAX2 ATF4 ATP2B2 | 4.44e-04 | 730 | 173 | 16 | GO:0007423 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | MAP1B PPM1E ZDHHC5 PUM2 AMBRA1 SYNPO POU4F2 CORO1B WNK1 INO80D MAP3K1 SETDB1 VPS13D KIDINS220 MAVS DDHD1 SASS6 GRIP2 MAP3K13 ULK1 PAN3 RAPGEF2 HTT AMIGO2 | 4.65e-04 | 1366 | 173 | 24 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of autophagy of mitochondrion | 5.09e-04 | 19 | 173 | 3 | GO:1903599 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 MAP1B SZT2 PPFIA2 ALS2 POU4F2 POU4F3 CORO1B RUNX3 KANK1 KIDINS220 CELSR3 SIPA1L1 VAX2 MAP3K13 ULK1 RAPGEF2 | 5.46e-04 | 819 | 173 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 6.30e-04 | 124 | 173 | 6 | GO:0001704 | |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 7.55e-04 | 49 | 173 | 4 | GO:0035137 | |
| GeneOntologyBiologicalProcess | eye development | RARB TTLL5 POU4F2 MED1 SIX3 MFRP MAP3K1 PRDM1 KMT2C VAX2 ATF4 ATP2B2 | 7.61e-04 | 480 | 173 | 12 | GO:0001654 |
| GeneOntologyBiologicalProcess | visual system development | RARB TTLL5 POU4F2 MED1 SIX3 MFRP MAP3K1 PRDM1 KMT2C VAX2 ATF4 ATP2B2 | 8.03e-04 | 483 | 173 | 12 | GO:0150063 |
| GeneOntologyCellularComponent | Golgi lumen | 3.10e-07 | 109 | 173 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | transcription regulator complex | TBX15 HNF1A SALL4 POU4F2 POU4F3 SIX4 RUNX2 MED1 SIX3 RUNX3 BATF2 GMNN NCOR2 SALL1 NFATC3 ATF4 PRKDC SMAD1 PROP1 | 5.51e-07 | 596 | 173 | 19 | GO:0005667 |
| GeneOntologyCellularComponent | somatodendritic compartment | GPC1 TANC2 HTR5A HTR6 MAP1B PPFIA2 ZDHHC5 PUM2 ALS2 SYNPO INPP5F KCNB1 KCND3 TP63 SIPA1L1 KCNN3 MAST1 ATF4 GRIP2 ULK1 RAPGEF2 ATP2B1 ATP2B2 IL6R HTT PDE11A | 9.60e-06 | 1228 | 173 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | chromatin | TBX15 HNF1A PCGF2 RARB SALL4 CHD1 POU4F2 POU4F3 SIX4 RUNX2 MED1 SIX3 RUNX3 BATF2 INO80D TBX19 NCOR2 SALL1 NFATC3 TP63 EHMT1 VAX2 TBXT BICRAL ATF4 PRKDC OBI1 SMAD1 PROP1 | 1.21e-05 | 1480 | 173 | 29 | GO:0000785 |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 ANK2 HTR5A MAP1B PPFIA2 ZDHHC5 ALS2 SYNPO PRR12 CELSR3 KCNB1 KCND3 SIPA1L1 GRIP2 ATP2B2 | 2.00e-05 | 503 | 173 | 15 | GO:0099572 |
| GeneOntologyCellularComponent | neuronal cell body | GPC1 HTR5A MAP1B PUM2 ALS2 SYNPO INPP5F KCNB1 KCND3 SIPA1L1 KCNN3 MAST1 GRIP2 ULK1 RAPGEF2 ATP2B1 ATP2B2 IL6R HTT PDE11A | 2.03e-05 | 835 | 173 | 20 | GO:0043025 |
| GeneOntologyCellularComponent | dendrite | TANC2 HTR5A HTR6 MAP1B PPFIA2 ZDHHC5 PUM2 ALS2 SYNPO INPP5F KCNB1 KCND3 TP63 SIPA1L1 MAST1 ATF4 GRIP2 ATP2B1 ATP2B2 HTT | 2.98e-05 | 858 | 173 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 HTR5A HTR6 MAP1B PPFIA2 ZDHHC5 PUM2 ALS2 SYNPO INPP5F KCNB1 KCND3 TP63 SIPA1L1 MAST1 ATF4 GRIP2 ATP2B1 ATP2B2 HTT | 3.08e-05 | 860 | 173 | 20 | GO:0097447 |
| GeneOntologyCellularComponent | neuron spine | TANC2 MAP1B PPFIA2 ALS2 SYNPO KCND3 SIPA1L1 GRIP2 ATP2B1 ATP2B2 | 4.17e-05 | 247 | 173 | 10 | GO:0044309 |
| GeneOntologyCellularComponent | cell body | GPC1 HTR5A MAP1B PUM2 ALS2 SYNPO INPP5F KCNB1 KCND3 SIPA1L1 KCNN3 MAST1 GRIP2 ULK1 RAPGEF2 ATP2B1 ATP2B2 IL6R HTT PDE11A | 8.96e-05 | 929 | 173 | 20 | GO:0044297 |
| GeneOntologyCellularComponent | dendritic spine | 1.92e-04 | 242 | 173 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | apical plasma membrane | ANK2 GPR143 MFRP KCNB1 MUC17 CD34 MTCL1 RAPGEF2 MUC4 ATP2B1 ATP2B2 IL6R SLC4A11 | 2.17e-04 | 487 | 173 | 13 | GO:0016324 |
| GeneOntologyCellularComponent | neuronal cell body membrane | 4.35e-04 | 43 | 173 | 4 | GO:0032809 | |
| GeneOntologyCellularComponent | cell body membrane | 6.12e-04 | 47 | 173 | 4 | GO:0044298 | |
| GeneOntologyCellularComponent | dendrite membrane | 1.19e-03 | 56 | 173 | 4 | GO:0032590 | |
| GeneOntologyCellularComponent | apical part of cell | ANK2 GPR143 MFRP KCNB1 MUC17 CD34 MTCL1 RAPGEF2 MUC4 ATP2B1 ATP2B2 IL6R SLC4A11 | 1.34e-03 | 592 | 173 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.97e-03 | 107 | 173 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.97e-03 | 107 | 173 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | postsynapse | TANC2 ANK2 HTR5A MAP1B PPFIA2 ZDHHC5 ALS2 SYNPO PRR12 CELSR3 KCNB1 KCND3 SIPA1L1 GRIP2 RAPGEF2 ATP2B1 ATP2B2 HTT | 1.99e-03 | 1018 | 173 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | nonhomologous end joining complex | 2.36e-03 | 9 | 173 | 2 | GO:0070419 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 2.47e-03 | 164 | 173 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | late endosome | KIDINS220 LAMP3 STARD3 CD68 SIGLEC1 RAPGEF2 PIP4P2 TRAPPC9 HTT | 2.52e-03 | 348 | 173 | 9 | GO:0005770 |
| GeneOntologyCellularComponent | actomyosin | 2.91e-03 | 117 | 173 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 3.02e-03 | 118 | 173 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | cell leading edge | ALS2 CORO1B PLEKHG5 CTTNBP2NL KANK1 DLC1 KCNB1 AMOT ATF4 ATP2B1 ATP2B2 | 3.07e-03 | 500 | 173 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 MAP1B PPFIA2 ZDHHC5 ALS2 SYNPO CORO1B PPFIA3 CELSR3 SIPA1L1 GRIP2 ATP2B1 ATP2B2 ATP2B3 HTT | 3.32e-03 | 817 | 173 | 15 | GO:0098978 |
| MousePheno | absent carpal bone | 1.27e-05 | 5 | 153 | 3 | MP:0000555 | |
| MousePheno | conductive hearing loss | 2.94e-05 | 17 | 153 | 4 | MP:0004739 | |
| MousePheno | abnormal cervical axis morphology | 3.17e-05 | 34 | 153 | 5 | MP:0004608 | |
| MousePheno | abnormal odontoid process morphology | 3.75e-05 | 18 | 153 | 4 | MP:0004659 | |
| MousePheno | conductive hearing impairment | 4.71e-05 | 19 | 153 | 4 | MP:0006326 | |
| MousePheno | decreased cell proliferation | ELOA SALL4 EYA1 MED1 RUNX3 GMNN KMT2C SETDB1 MAVS DCLRE1C TP63 CD34 KMT2A IRS2 ATF4 PRKDC RAPGEF2 IL6R TNS3 HTT SMG6 | 5.50e-05 | 739 | 153 | 21 | MP:0000352 |
| MousePheno | impaired gluconeogenesis | 6.92e-05 | 8 | 153 | 3 | MP:0030973 | |
| MousePheno | absent triquetrum | 1.19e-04 | 2 | 153 | 2 | MP:0030862 | |
| Domain | DUF1908 | 6.79e-09 | 4 | 171 | 4 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 6.79e-09 | 4 | 171 | 4 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 6.79e-09 | 4 | 171 | 4 | IPR023142 | |
| Domain | - | 6.79e-09 | 4 | 171 | 4 | 1.20.1480.20 | |
| Domain | p53-like_TF_DNA-bd | 5.16e-07 | 53 | 171 | 7 | IPR008967 | |
| Domain | ATP_Ca_trans_C | 3.00e-06 | 4 | 171 | 3 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 3.00e-06 | 4 | 171 | 3 | PF12424 | |
| Domain | Tensin_PTB | 3.00e-06 | 4 | 171 | 3 | IPR033929 | |
| Domain | P-type_ATPase_IIB | 3.00e-06 | 4 | 171 | 3 | IPR006408 | |
| Domain | FYrich_C | 7.44e-06 | 5 | 171 | 3 | IPR003889 | |
| Domain | FYrich_N | 7.44e-06 | 5 | 171 | 3 | IPR003888 | |
| Domain | FYRC | 7.44e-06 | 5 | 171 | 3 | SM00542 | |
| Domain | FYRN | 7.44e-06 | 5 | 171 | 3 | SM00541 | |
| Domain | FYRN | 7.44e-06 | 5 | 171 | 3 | PF05964 | |
| Domain | FYRC | 7.44e-06 | 5 | 171 | 3 | PF05965 | |
| Domain | FYRC | 7.44e-06 | 5 | 171 | 3 | PS51543 | |
| Domain | FYRN | 7.44e-06 | 5 | 171 | 3 | PS51542 | |
| Domain | VWF_type-D | 1.13e-05 | 16 | 171 | 4 | IPR001846 | |
| Domain | VWFD | 1.13e-05 | 16 | 171 | 4 | PS51233 | |
| Domain | VWD | 1.13e-05 | 16 | 171 | 4 | SM00216 | |
| Domain | VWD | 1.13e-05 | 16 | 171 | 4 | PF00094 | |
| Domain | p53/RUNT-type_TF_DNA-bd | 1.48e-05 | 6 | 171 | 3 | IPR012346 | |
| Domain | - | 1.48e-05 | 6 | 171 | 3 | 2.60.40.720 | |
| Domain | SET | 3.48e-05 | 41 | 171 | 5 | PF00856 | |
| Domain | PTEN_C2 | 4.08e-05 | 8 | 171 | 3 | PF10409 | |
| Domain | PTB | 4.08e-05 | 8 | 171 | 3 | IPR013625 | |
| Domain | PTEN_C2 | 4.08e-05 | 8 | 171 | 3 | SM01326 | |
| Domain | PTB | 4.08e-05 | 8 | 171 | 3 | PF08416 | |
| Domain | C2_TENSIN | 4.08e-05 | 8 | 171 | 3 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 4.08e-05 | 8 | 171 | 3 | IPR029023 | |
| Domain | Tensin_C2-dom | 4.08e-05 | 8 | 171 | 3 | IPR014020 | |
| Domain | PDZ | 4.72e-05 | 141 | 171 | 8 | PF00595 | |
| Domain | SEA | 5.24e-05 | 23 | 171 | 4 | PS50024 | |
| Domain | SEA_dom | 5.24e-05 | 23 | 171 | 4 | IPR000082 | |
| Domain | PPASE_TENSIN | 6.08e-05 | 9 | 171 | 3 | PS51181 | |
| Domain | SET | 6.14e-05 | 46 | 171 | 5 | SM00317 | |
| Domain | PDZ | 6.65e-05 | 148 | 171 | 8 | SM00228 | |
| Domain | - | 7.31e-05 | 150 | 171 | 8 | 2.30.42.10 | |
| Domain | PDZ | 7.66e-05 | 151 | 171 | 8 | PS50106 | |
| Domain | PDZ | 8.03e-05 | 152 | 171 | 8 | IPR001478 | |
| Domain | SET_dom | 9.21e-05 | 50 | 171 | 5 | IPR001214 | |
| Domain | SET | 9.21e-05 | 50 | 171 | 5 | PS50280 | |
| Domain | C8 | 1.56e-04 | 12 | 171 | 3 | PF08742 | |
| Domain | TIL | 1.56e-04 | 12 | 171 | 3 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 2.02e-04 | 13 | 171 | 3 | IPR014853 | |
| Domain | C8 | 2.02e-04 | 13 | 171 | 3 | SM00832 | |
| Domain | Runt | 2.49e-04 | 3 | 171 | 2 | PF00853 | |
| Domain | RUNT | 2.49e-04 | 3 | 171 | 2 | PS51062 | |
| Domain | TF_Runt-rel_RUNX | 2.49e-04 | 3 | 171 | 2 | IPR016554 | |
| Domain | RunxI | 2.49e-04 | 3 | 171 | 2 | PF08504 | |
| Domain | DRMBL | 2.49e-04 | 3 | 171 | 2 | IPR011084 | |
| Domain | Runt_dom | 2.49e-04 | 3 | 171 | 2 | IPR013524 | |
| Domain | RunxI_C_dom | 2.49e-04 | 3 | 171 | 2 | IPR013711 | |
| Domain | Runx_central_dom | 2.49e-04 | 3 | 171 | 2 | IPR027384 | |
| Domain | - | 2.49e-04 | 3 | 171 | 2 | 4.10.770.10 | |
| Domain | DRMBL | 2.49e-04 | 3 | 171 | 2 | PF07522 | |
| Domain | AML1_Runt | 2.49e-04 | 3 | 171 | 2 | IPR000040 | |
| Domain | TIL_dom | 2.55e-04 | 14 | 171 | 3 | IPR002919 | |
| Domain | SEA | 2.55e-04 | 14 | 171 | 3 | SM00200 | |
| Domain | Post-SET_dom | 3.87e-04 | 16 | 171 | 3 | IPR003616 | |
| Domain | PostSET | 3.87e-04 | 16 | 171 | 3 | SM00508 | |
| Domain | ATPase_P-typ_TM_dom | 3.87e-04 | 16 | 171 | 3 | IPR023298 | |
| Domain | AT_hook | 3.87e-04 | 16 | 171 | 3 | PF02178 | |
| Domain | - | 3.87e-04 | 16 | 171 | 3 | 1.20.1110.10 | |
| Domain | POST_SET | 3.87e-04 | 16 | 171 | 3 | PS50868 | |
| Domain | TF_T-box | 4.67e-04 | 17 | 171 | 3 | IPR001699 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.67e-04 | 17 | 171 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.67e-04 | 17 | 171 | 3 | PF00689 | |
| Domain | TBOX | 4.67e-04 | 17 | 171 | 3 | SM00425 | |
| Domain | TF_T-box_CS | 4.67e-04 | 17 | 171 | 3 | IPR018186 | |
| Domain | - | 4.67e-04 | 17 | 171 | 3 | 2.60.40.820 | |
| Domain | TBOX_3 | 4.67e-04 | 17 | 171 | 3 | PS50252 | |
| Domain | T-box | 4.67e-04 | 17 | 171 | 3 | PF00907 | |
| Domain | TBOX_1 | 4.67e-04 | 17 | 171 | 3 | PS01283 | |
| Domain | TBOX_2 | 4.67e-04 | 17 | 171 | 3 | PS01264 | |
| Domain | LAMP_3 | 4.94e-04 | 4 | 171 | 2 | PS51407 | |
| Domain | Cation_ATPase_N | 5.56e-04 | 18 | 171 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 5.56e-04 | 18 | 171 | 3 | SM00831 | |
| Domain | SAM_2 | 6.34e-04 | 43 | 171 | 4 | PF07647 | |
| Domain | VWC_out | 6.56e-04 | 19 | 171 | 3 | SM00215 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.56e-04 | 19 | 171 | 3 | IPR004014 | |
| Domain | - | 7.67e-04 | 20 | 171 | 3 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 7.67e-04 | 20 | 171 | 3 | IPR001279 | |
| Domain | Lamp | 8.18e-04 | 5 | 171 | 2 | PF01299 | |
| Domain | Lysosome-assoc_membr_glycop | 8.18e-04 | 5 | 171 | 2 | IPR002000 | |
| Domain | SEA | 1.02e-03 | 22 | 171 | 3 | PF01390 | |
| Domain | CT | 1.02e-03 | 22 | 171 | 3 | SM00041 | |
| Domain | OSR1_C | 1.22e-03 | 6 | 171 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.22e-03 | 6 | 171 | 2 | IPR024678 | |
| Domain | TF_Brachyury | 1.22e-03 | 6 | 171 | 2 | IPR002070 | |
| Domain | Liprin | 1.22e-03 | 6 | 171 | 2 | IPR029515 | |
| Domain | WxxW_domain | 1.22e-03 | 6 | 171 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.22e-03 | 6 | 171 | 2 | PF13330 | |
| Domain | tRNA-bd_arm | 1.32e-03 | 24 | 171 | 3 | IPR010978 | |
| Domain | Cys_knot_C | 1.50e-03 | 25 | 171 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.50e-03 | 25 | 171 | 3 | PS01225 | |
| Domain | Pre-SET | 1.70e-03 | 7 | 171 | 2 | PF05033 | |
| Domain | SIX1_SD | 1.70e-03 | 7 | 171 | 2 | IPR031701 | |
| Domain | PreSET | 1.70e-03 | 7 | 171 | 2 | SM00468 | |
| Domain | SIX1_SD | 1.70e-03 | 7 | 171 | 2 | PF16878 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.46e-13 | 16 | 124 | 8 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 6.49e-13 | 17 | 124 | 8 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.25e-11 | 23 | 124 | 8 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.90e-11 | 26 | 124 | 8 | M27483 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.00e-08 | 21 | 124 | 6 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 6.49e-08 | 62 | 124 | 8 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.36e-07 | 68 | 124 | 8 | M27303 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 3.92e-06 | 140 | 124 | 9 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.66e-06 | 143 | 124 | 9 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.92e-06 | 111 | 124 | 8 | M27416 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.39e-05 | 60 | 124 | 6 | MM15636 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.38e-04 | 12 | 124 | 3 | M27326 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 1.66e-04 | 59 | 124 | 5 | M46460 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 1.78e-04 | 13 | 124 | 3 | M47440 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.25e-04 | 14 | 124 | 3 | MM15052 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.62e-04 | 250 | 124 | 9 | M27554 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.97e-04 | 109 | 124 | 6 | MM15164 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 RALGAPA1 ATXN2L MAP1B KIF26B ALS2 CBARP FAM117B INPP5F MAST2 WNK1 SHKBP1 KIAA1671 ZNF106 VPS13D DLC1 MAST4 NFATC3 AMOT N4BP2 SIPA1L1 SEC24B KMT2A IRS2 MTCL1 PAN3 RAPGEF2 SRRM2 ATP2B1 OBI1 TRAPPC9 TNS3 CRTC2 CCSER1 | 1.67e-20 | 861 | 178 | 34 | 36931259 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.68e-14 | 18 | 178 | 8 | 18834073 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 SZT2 ZDHHC5 AMBRA1 SLC10A3 CORO1B MAST2 WNK1 PLEKHG5 PRR12 KMT2C NCOR2 KLHL25 CELSR3 ZNF592 EHMT1 LRRC56 UNKL IRS2 DTX2 PRKDC ULK1 TRAPPC9 WNK2 HTT SMG6 | 9.98e-11 | 1105 | 178 | 26 | 35748872 |
| Pubmed | RALGAPA1 SZT2 AMBRA1 SYNPO INPP5F PLEKHG5 CTTNBP2NL PASK KMT2C MAST4 CELSR3 ZNF592 AMOT DDHD1 EHMT1 RPRD2 WNK2 SMG6 | 3.13e-10 | 529 | 178 | 18 | 14621295 | |
| Pubmed | TANC2 RALGAPA1 INPP5F MAST2 WNK1 CTTNBP2NL SHKBP1 KIAA1671 AMOT SIPA1L1 IRS2 PRKDC MTCL1 RAPGEF2 TRAPPC9 CRTC2 | 1.49e-09 | 446 | 178 | 16 | 24255178 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX15 HNF1A RARB POU4F2 POU4F3 SIX4 RUNX2 SIX3 RUNX3 BATF2 PRDM1 TBX19 SALL1 NFATC3 TP63 KMT2A UNKL VAX2 TBXT ATF4 SMAD1 PROP1 | 1.83e-09 | 908 | 178 | 22 | 19274049 |
| Pubmed | PUM2 ALS2 PPFIA3 WNK1 PASK KMT2C AMOT SIPA1L1 EHMT1 RPRD2 GRIP2 SMG6 | 2.25e-09 | 225 | 178 | 12 | 12168954 | |
| Pubmed | 3.30e-09 | 5 | 178 | 4 | 17190795 | ||
| Pubmed | KIF26B SYNPO MUC12 WNK1 KMT2C ZNF106 SETDB1 N4BP2 IRAG2 BICRAL ATF4 PRKDC RAPGEF2 TNS1 OBI1 WNK2 | 5.05e-09 | 486 | 178 | 16 | 20936779 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | TBX15 ELOA HNF1A PCGF2 RARB SALL4 POU4F2 RUNX2 MED1 RUNX1T1 RUNX3 TBX19 NCOR2 NFATC3 ZNF592 TP63 CARF EHMT1 VAX2 ATF4 SMAD1 | 5.39e-09 | 877 | 178 | 21 | 20211142 |
| Pubmed | 9.87e-09 | 6 | 178 | 4 | 19110483 | ||
| Pubmed | KIF26B CTTNBP2NL KIAA1671 PASK VPS13D KIDINS220 MAST4 SIPA1L1 LTV1 MTCL1 TNS3 | 1.23e-08 | 209 | 178 | 11 | 36779422 | |
| Pubmed | COL17A1 PUM2 MAST2 SETDB1 VPS13D CELSR3 SIPA1L1 BICRAL MAST3 | 2.55e-08 | 130 | 178 | 9 | 12421765 | |
| Pubmed | PPM1E FRMPD1 PUM2 ALS2 CSMD3 IGDCC4 SETDB1 KANK1 KIDINS220 SIPA1L1 MAST1 MTCL1 ULK1 SRRM2 | 2.77e-08 | 407 | 178 | 14 | 12693553 | |
| Pubmed | TANC2 ATXN2L ANK2 MAP1B PPFIA2 ZDHHC5 CBARP SYNPO KCNB1 SIPA1L1 SRRM2 ATP2B2 HTT | 3.27e-08 | 347 | 178 | 13 | 17114649 | |
| Pubmed | SETDB1 is essential for mouse primordial germ cell fate determination by ensuring BMP signaling. | 4.57e-08 | 8 | 178 | 4 | 30446626 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ZC3H13 ZDHHC5 VWA7 MAST2 CELSR3 ZNF592 MACO1 IRS2 PRKDC MTCL1 SRRM2 OBI1 TNS3 | 5.19e-08 | 361 | 178 | 13 | 26167880 |
| Pubmed | HNF1A DTNA PUM2 PROSER1 SIX4 INO80D IKZF5 PRDM1 KIAA1671 PRR12 KMT2C NCOR2 SETDB1 SALL1 NFATC3 ZNF592 SEC24B EHMT1 KMT2A TBXT RPRD2 LTV1 PAN3 SRRM2 TRAPPC9 | 8.57e-08 | 1429 | 178 | 25 | 35140242 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 MAP1B DTNA PPFIA2 FRMPD1 SYNPO FAM117B SHKBP1 KIAA1671 KMT2C NCOR2 KIDINS220 KCND3 EHMT1 MAST1 RPRD2 PAN3 RAPGEF2 CSMD1 ATP2B1 TRAPPC9 IL6R WNK2 HTT SMG6 | 1.86e-07 | 1489 | 178 | 25 | 28611215 |
| Pubmed | GPC1 TANC2 RALGAPA1 ATXN2L ANK2 MAP1B PPFIA2 SYNPO CORO1B PPFIA3 PLEKHG5 KIDINS220 KCND3 AMOT SIPA1L1 MAST1 KMT2A RAPGEF2 TNS1 ATP2B1 ATP2B2 ATP2B3 TRAPPC9 WNK2 | 3.42e-07 | 1431 | 178 | 24 | 37142655 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | GPC1 TANC2 MAP1B PPFIA2 SYNPO PPFIA3 KCNB1 SIPA1L1 SRRM2 MAST3 | 3.54e-07 | 231 | 178 | 10 | 16452087 |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 5.25e-07 | 4 | 178 | 3 | 12209837 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 5.25e-07 | 4 | 178 | 3 | 8245032 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 15951562 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 5.25e-07 | 4 | 178 | 3 | 7989379 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 23807779 | ||
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 5.25e-07 | 4 | 178 | 3 | 36130203 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 14984930 | ||
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 10577388 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 5.25e-07 | 4 | 178 | 3 | 29869461 | |
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 5.25e-07 | 4 | 178 | 3 | 8634322 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 12784250 | ||
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 5.25e-07 | 4 | 178 | 3 | 11152753 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 5.25e-07 | 4 | 178 | 3 | 10434059 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 19194507 | ||
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 15101689 | ||
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 17471237 | ||
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 12676567 | ||
| Pubmed | 6.82e-07 | 191 | 178 | 9 | 24146773 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | TBX15 RARB POU4F3 SIX4 RUNX2 SIX3 RUNX3 PRDM1 TBX19 NFATC3 VAX2 TBXT ATF4 PROP1 | 9.30e-07 | 544 | 178 | 14 | 28473536 |
| Pubmed | 1.00e-06 | 102 | 178 | 7 | 11214970 | ||
| Pubmed | 1.26e-06 | 152 | 178 | 8 | 38360978 | ||
| Pubmed | TANC2 AMBRA1 PPFIA3 MAST2 INO80D KIAA1671 PASK NCOR2 SETDB1 ZNF592 SIPA1L1 EHMT1 VAX2 BICRAL IRS2 SIGLEC1 RAPGEF2 CSMD1 SRRM2 SLC4A11 | 1.30e-06 | 1116 | 178 | 20 | 31753913 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 1.31e-06 | 5 | 178 | 3 | 11062147 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 1.31e-06 | 5 | 178 | 3 | 16475027 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 17938178 | ||
| Pubmed | RALGAPA1 ATXN2L ELOA PUM2 CHD1 CORO1B WNK1 ZNF106 SETDB1 KANK1 MAVS N4BP2 MACO1 DDHD1 RPRD2 TNS3 | 1.32e-06 | 733 | 178 | 16 | 34672954 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | PUM2 SALL4 PROSER1 CHD1 MED1 RUNX1T1 NCOR2 SALL1 AMOT KMT2A PRKDC SRRM2 | 1.57e-06 | 411 | 178 | 12 | 35182466 |
| Pubmed | Calcineurin signaling regulates neural induction through antagonizing the BMP pathway. | 1.92e-06 | 18 | 178 | 4 | 24698271 | |
| Pubmed | RALGAPA1 ELOA DTNA PPM1E ZDHHC5 TNS2 CBARP EYA1 SIX4 PPFIA3 SHKBP1 KIAA1671 NCOR2 MACO1 SEC24B SRRM2 TNS1 ATP2B1 TNS3 | 2.08e-06 | 1049 | 178 | 19 | 27880917 | |
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 2.61e-06 | 6 | 178 | 3 | 12767889 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 3.77e-06 | 235 | 178 | 9 | 30258100 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TANC2 ELOA AMBRA1 FAM117B CORO1B MED1 WNK1 KIAA1671 SETDB1 AMOT DDHD1 SIPA1L1 SEC24B LTV1 PAN3 PIP4P2 MUC5AC ATP2B2 TRAPPC9 MAST3 CRTC2 | 4.52e-06 | 1321 | 178 | 21 | 27173435 |
| Pubmed | TBX15 HNF1A ZC3H13 ZDHHC5 SALL4 SIX4 RUNX2 RUNX3 IKZF5 PRDM1 TBX19 SALL1 ZNF592 TBXT ATF4 SMAD1 | 4.58e-06 | 808 | 178 | 16 | 20412781 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATXN2L ELOA ANK2 MAP1B PUM2 CHD1 CORO1B MED1 WNK1 KIAA1671 MAVS SEC24B KMT2A RPRD2 LTV1 IRS2 PRKDC | 6.92e-06 | 934 | 178 | 17 | 33916271 |
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 10531362 | ||
| Pubmed | Critical function of Prdm14 for the establishment of the germ cell lineage in mice. | 7.24e-06 | 8 | 178 | 3 | 18622394 | |
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 10951186 | ||
| Pubmed | 8.84e-06 | 331 | 178 | 10 | 20634891 | ||
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 38386912 | ||
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 12923177 | ||
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 18470945 | ||
| Pubmed | INPP5F KIAA1671 PRR12 NCOR2 SETDB1 SALL1 ZNF592 AMOT N4BP2 IRS2 OBI1 | 1.15e-05 | 418 | 178 | 11 | 34709266 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L ELOA ZC3H13 PUM2 MED1 CTTNBP2NL PASK NCOR2 ZNF106 ZNF592 SIPA1L1 KMT2A IRS2 PRKDC SRRM2 | 1.18e-05 | 774 | 178 | 15 | 15302935 |
| Pubmed | Rebalancing gene haploinsufficiency in vivo by targeting chromatin. | 1.23e-05 | 28 | 178 | 4 | 27256596 | |
| Pubmed | RALGAPA1 DTNA FRMPD1 SYNPO PPFIA3 AMOT SIPA1L1 MAST1 MAP3K13 RAPGEF2 ATP2B1 | 1.49e-05 | 430 | 178 | 11 | 32581705 | |
| Pubmed | Enhancer activation requires trans-recruitment of a mega transcription factor complex. | 1.54e-05 | 10 | 178 | 3 | 25303530 | |
| Pubmed | 2.42e-05 | 33 | 178 | 4 | 18356246 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 2.60e-05 | 2 | 178 | 2 | 14988081 | |
| Pubmed | Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. | 2.60e-05 | 2 | 178 | 2 | 19476507 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 17621824 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 22220206 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 24317696 | ||
| Pubmed | Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration. | 2.60e-05 | 2 | 178 | 2 | 11792844 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 25538041 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 2.60e-05 | 2 | 178 | 2 | 35776514 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 19440389 | ||
| Pubmed | Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. | 2.60e-05 | 2 | 178 | 2 | 22726846 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 24327612 | ||
| Pubmed | NFATc3 regulates Kv2.1 expression in arterial smooth muscle. | 2.60e-05 | 2 | 178 | 2 | 15322114 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 31030254 | ||
| Pubmed | Identification of sequence variants influencing immunoglobulin levels. | 2.60e-05 | 2 | 178 | 2 | 28628107 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 16540890 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 27435107 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 26871672 | ||
| Pubmed | A biochemically defined system for mammalian nonhomologous DNA end joining. | 2.60e-05 | 2 | 178 | 2 | 15574326 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 11988092 | ||
| Pubmed | Structural analysis of the basal state of the Artemis:DNA-PKcs complex. | 2.60e-05 | 2 | 178 | 2 | 35801871 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 14690056 | ||
| Pubmed | The Artemis:DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps. | 2.60e-05 | 2 | 178 | 2 | 15936993 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 34331233 | ||
| Pubmed | The role of DNA-PKcs and artemis in opening viral DNA hairpin termini in various tissues in mice. | 2.60e-05 | 2 | 178 | 2 | 17686847 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 17932067 | ||
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 2.60e-05 | 2 | 178 | 2 | 24722639 | |
| Pubmed | WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia. | 2.60e-05 | 2 | 178 | 2 | 35849656 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 2.60e-05 | 2 | 178 | 2 | 34656442 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 20519941 | ||
| Interaction | YWHAG interactions | TANC2 RALGAPA1 ATXN2L HNF1A KIF26B ZC3H13 TNS2 ALS2 CBARP SYNPO FAM117B INPP5F MAST2 WNK1 PLEKHG5 MAP3K1 SHKBP1 KIAA1671 ZNF106 VPS13D KANK1 DLC1 MAST4 NFATC3 AMOT N4BP2 SIPA1L1 SEC24B KMT2A IRS2 PRKDC MTCL1 ULK1 PAN3 RAPGEF2 SRRM2 TRAPPC9 MAST3 TNS3 HTT CRTC2 CCSER1 | 1.65e-14 | 1248 | 175 | 42 | int:YWHAG |
| Interaction | YWHAH interactions | GPC1 TANC2 RALGAPA1 ATXN2L KIF26B ZC3H13 TNS2 ALS2 CBARP FAM117B INPP5F MED1 MAST2 WNK1 PLEKHG5 SHKBP1 KIAA1671 ZNF106 VPS13D KANK1 MAST4 NFATC3 AMOT SIPA1L1 SEC24B MAST1 KMT2A IRS2 MTCL1 PAN3 RAPGEF2 SRRM2 TRAPPC9 WNK2 MAST3 TNS3 HTT CRTC2 CCSER1 | 3.53e-14 | 1102 | 175 | 39 | int:YWHAH |
| Interaction | YWHAZ interactions | TANC2 RALGAPA1 ATXN2L ELOA HNF1A KIF26B PPFIA2 TEDC2 ALS2 CBARP SYNPO FAM117B INPP5F PPFIA3 MAST2 WNK1 PLEKHG5 MAP3K1 KIAA1671 VPS13D KANK1 MAST4 NFATC3 MACO1 SIPA1L1 IRAG2 MAST1 KMT2A IRS2 ULK1 RAPGEF2 TNS1 ATP2B1 ATP2B2 WNK2 MAST3 HTT CRTC2 CCSER1 | 9.65e-12 | 1319 | 175 | 39 | int:YWHAZ |
| Interaction | YWHAB interactions | TANC2 RALGAPA1 ATXN2L HNF1A KIF26B TNS2 ALS2 CBARP FAM117B INPP5F MAST2 WNK1 PLEKHG5 SHKBP1 KIAA1671 ZNF106 VPS13D KANK1 MAST4 NFATC3 AMOT SIPA1L1 MAST1 KMT2A IRS2 MTCL1 RAPGEF2 SRRM2 MAST3 TNS3 HTT CRTC2 CCSER1 | 4.28e-11 | 1014 | 175 | 33 | int:YWHAB |
| Interaction | SFN interactions | GPC1 TANC2 RALGAPA1 ATXN2L MAP1B KIF26B CBARP FAM117B INPP5F MAST2 WNK1 KIAA1671 MAST4 NFATC3 AMOT TP63 SIPA1L1 KMT2A IRS2 DTX2 PAN3 SRRM2 OBI1 TNS3 HTT CCSER1 | 3.16e-10 | 692 | 175 | 26 | int:SFN |
| Interaction | YWHAE interactions | GPC1 TANC2 RALGAPA1 ATXN2L ELOA HNF1A MAP1B KIF26B TNS2 ALS2 CBARP FAM117B INPP5F MAST2 WNK1 PLEKHG5 MAP3K1 KIAA1671 NCOR2 ZNF106 KANK1 MAST4 SIPA1L1 IRAG2 MAST1 KMT2A IRS2 ULK1 RAPGEF2 SRRM2 WNK2 MAST3 HTT CRTC2 CCSER1 | 6.76e-10 | 1256 | 175 | 35 | int:YWHAE |
| Interaction | YWHAQ interactions | GPC1 TANC2 RALGAPA1 ATXN2L KIF26B ZC3H13 ALS2 CBARP FAM117B INPP5F MED1 MAST2 WNK1 PLEKHG5 MAP3K1 KIAA1671 ZNF106 VPS13D KANK1 MAST4 NFATC3 MACO1 SIPA1L1 KMT2A IRS2 PRKDC PAN3 RAPGEF2 TNS3 HTT CRTC2 CCSER1 | 2.17e-09 | 1118 | 175 | 32 | int:YWHAQ |
| Interaction | MAST4 interactions | 2.65e-06 | 26 | 175 | 5 | int:MAST4 | |
| Interaction | TLE3 interactions | TBX15 PROSER1 SIX4 SIX3 INO80D PRDM1 PRR12 NCOR2 SALL1 KMT2A TBXT SRRM2 CRTC2 | 2.61e-05 | 376 | 175 | 13 | int:TLE3 |
| Interaction | CNOT9 interactions | 3.54e-05 | 231 | 175 | 10 | int:CNOT9 | |
| Interaction | SOX2 interactions | ATXN2L ELOA PCGF2 MAP1B PUM2 SALL4 PROSER1 CORO1B EYA1 SIX4 RUNX2 MED1 MAST2 KIAA1671 PRR12 KMT2C NCOR2 KIDINS220 SALL1 TP63 MACO1 SIPA1L1 EHMT1 KMT2A LTV1 ATF4 MAP3K13 SMG6 | 3.83e-05 | 1422 | 175 | 28 | int:SOX2 |
| Interaction | NCOA6 interactions | 3.99e-05 | 145 | 175 | 8 | int:NCOA6 | |
| Interaction | EYA4 interactions | 5.43e-05 | 243 | 175 | 10 | int:EYA4 | |
| Interaction | CGN interactions | 5.58e-05 | 152 | 175 | 8 | int:CGN | |
| Interaction | GSK3A interactions | KIF26B CTTNBP2NL KIAA1671 PASK VPS13D KANK1 KIDINS220 MAST4 SIPA1L1 LTV1 PRKDC MTCL1 SRRM2 TNS3 | 5.63e-05 | 464 | 175 | 14 | int:GSK3A |
| Interaction | FBXW11 interactions | UBL7 MAP1B AMBRA1 TNS2 CHD1 CBARP MAST2 PLEKHG5 SIPA1L1 IRS2 ATF4 INAVA RAPGEF2 MAST3 | 6.91e-05 | 473 | 175 | 14 | int:FBXW11 |
| Interaction | STYK1 interactions | 8.37e-05 | 161 | 175 | 8 | int:STYK1 | |
| Interaction | DYNLL2 interactions | AMBRA1 FAM117B CTTNBP2NL KMT2C KANK1 AMOT N4BP2 DDHD1 MAST1 MTCL1 | 1.05e-04 | 263 | 175 | 10 | int:DYNLL2 |
| Interaction | OCLN interactions | RALGAPA1 ANK2 KIF26B DTNA ZDHHC5 CBARP KIAA1671 KIDINS220 SIPA1L1 SEC24B LAMP3 ULK1 ATP2B1 CCSER1 | 1.24e-04 | 500 | 175 | 14 | int:OCLN |
| Interaction | FBXW12 interactions | 1.34e-04 | 12 | 175 | 3 | int:FBXW12 | |
| Interaction | C17orf78 interactions | 1.34e-04 | 12 | 175 | 3 | int:C17orf78 | |
| Interaction | ZYX interactions | UBL7 TANC2 ANK2 ALS2 CORO1B WNK1 KIAA1671 KIDINS220 AMOT N4BP2 SIPA1L1 | 1.48e-04 | 329 | 175 | 11 | int:ZYX |
| Interaction | MED15 interactions | 1.49e-04 | 131 | 175 | 7 | int:MED15 | |
| Interaction | NFIX interactions | 1.70e-04 | 227 | 175 | 9 | int:NFIX | |
| Interaction | TOP3B interactions | TANC2 SZT2 ZDHHC5 AMBRA1 SLC10A3 CORO1B MAST2 WNK1 PLEKHG5 PRR12 KMT2C NCOR2 KLHL25 CELSR3 ZNF592 SEC24B EHMT1 LRRC56 UNKL IRS2 DTX2 PRKDC ULK1 TRAPPC9 WNK2 HTT SMG6 | 1.71e-04 | 1470 | 175 | 27 | int:TOP3B |
| Interaction | RAPGEF5 interactions | 1.73e-04 | 60 | 175 | 5 | int:RAPGEF5 | |
| Interaction | CTNNB1 interactions | GPC1 TANC2 ATXN2L HNF1A ANK2 DTNA FAM117B CORO1B RUNX2 KIAA1671 SALL1 AMOT SIPA1L1 SEC24B MAST1 KMT2A PRKDC RAPGEF2 SRRM2 HTT PROP1 | 1.85e-04 | 1009 | 175 | 21 | int:CTNNB1 |
| GeneFamily | CD molecules|Mucins | 4.91e-13 | 21 | 118 | 8 | 648 | |
| GeneFamily | PDZ domain containing | 6.95e-06 | 152 | 118 | 8 | 1220 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.48e-05 | 8 | 118 | 3 | 837 | |
| GeneFamily | ATPases Ca2+ transporting | 2.21e-05 | 9 | 118 | 3 | 1209 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.87e-05 | 34 | 118 | 4 | 487 | |
| GeneFamily | T-boxes | 2.06e-04 | 18 | 118 | 3 | 766 | |
| GeneFamily | C2 tensin-type domain containing|PTEN protein phosphatases|Phosphoinositide phosphatases | 4.17e-04 | 5 | 118 | 2 | 902 | |
| GeneFamily | SINE class homeoboxes | 6.23e-04 | 6 | 118 | 2 | 525 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 7.88e-04 | 28 | 118 | 3 | 745 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 3.14e-03 | 13 | 118 | 2 | 170 | |
| GeneFamily | StAR related lipid transfer domain containing | 4.20e-03 | 15 | 118 | 2 | 759 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.69e-07 | 170 | 178 | 10 | M5880 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.41e-06 | 158 | 178 | 9 | MM17063 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | ANK2 MAP1B PPFIA2 MUC16 MAST2 CELSR3 MACO1 KCNN3 MAST1 BICRAL GRIP2 CSMD1 PIP4P2 ATP2B2 CCSER1 | 2.10e-06 | 506 | 178 | 15 | M39067 |
| Coexpression | HEVNER_INTERMEDIATE_ZONE_AND_UP_POSTMITOTIC_NEURONS | 4.88e-06 | 64 | 178 | 6 | MM408 | |
| Coexpression | LTE2_UP.V1_DN | 7.92e-06 | 195 | 178 | 9 | M2721 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 9.71e-06 | 200 | 178 | 9 | M6254 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 ANK2 MAP1B PPFIA2 SALL4 FAM117B RUNX1T1 SIX3 CSMD3 MAST4 CELSR3 N4BP2 MACO1 KCNN3 MAST1 GRIP2 CSMD1 ATP2B1 ATP2B2 PDE11A CCSER1 | 2.15e-05 | 1106 | 178 | 21 | M39071 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.34e-05 | 180 | 178 | 8 | M8239 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.17e-05 | 300 | 178 | 10 | M8702 | |
| Coexpression | GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN | 6.33e-05 | 197 | 178 | 8 | M9708 | |
| Coexpression | GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 6.33e-05 | 197 | 178 | 8 | M5351 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 | ZC3H13 MED1 PRDM1 VPS13D MAVS TP63 KCNN3 MAST1 TRAPPC9 LRRC36 | 6.78e-05 | 318 | 178 | 10 | M2429 |
| Coexpression | GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP | 6.80e-05 | 199 | 178 | 8 | M6395 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 7.04e-05 | 200 | 178 | 8 | M302 | |
| Coexpression | GSE30083_SP1_VS_SP4_THYMOCYTE_DN | 7.04e-05 | 200 | 178 | 8 | M5030 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAP1B PUM2 CHD1 INPP5F MED1 MAST2 NCOR2 SETDB1 KIDINS220 DLC1 NFATC3 SIPA1L1 SEC24B BICRAL MTCL1 RAPGEF2 ATP2B1 | 7.95e-05 | 856 | 178 | 17 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | ANK2 MAP1B PPFIA2 FAM117B EYA1 RUNX1T1 SIX3 CELSR3 MACO1 MAST1 GRIP2 PDE11A | 8.59e-05 | 465 | 178 | 12 | M39066 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_200 | TBX15 COL17A1 KIF26B SALL4 EYA1 RUNX2 RUNX1T1 RUNX3 PRDM1 SYT16 TP63 | 1.45e-07 | 169 | 173 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | TBX15 TANC2 COL17A1 ANK2 KIF26B PPM1E FRMPD1 PUM2 SALL4 CHD1 SYNPO DCLRE1B EYA1 SIX4 RUNX2 RUNX1T1 RUNX3 CTTNBP2NL PRDM1 SYT16 SALL1 DLC1 TP63 | 4.50e-07 | 850 | 173 | 23 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_100 | 8.59e-07 | 92 | 173 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.39e-06 | 98 | 173 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_200 | TBX15 COL17A1 KIF26B SALL4 EYA1 RUNX2 RUNX1T1 PRDM1 SYT16 TP63 | 1.78e-06 | 175 | 173 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200 | 5.79e-06 | 157 | 173 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_100 | 6.10e-06 | 85 | 173 | 7 | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | TBX15 COL17A1 KIF26B SALL4 EYA1 SIX4 RUNX2 RUNX1T1 RUNX3 CTTNBP2NL PRDM1 SYT16 SALL1 TP63 | 1.16e-05 | 428 | 173 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | TANC2 RARB ANK2 MAP1B KIF26B SALL4 EYA1 SIX4 RUNX1T1 CSMD3 SYT16 SETDB1 SALL1 DLC1 TP63 RPRD2 ATP2B1 SMAD1 AMIGO2 CCSER1 | 1.21e-05 | 818 | 173 | 20 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TANC2 RALGAPA1 RARB COL17A1 ANK2 MAP1B KIF26B PUM2 SALL4 CHD1 EYA1 MED1 RUNX1T1 WNK1 DLC1 CELSR3 TP63 SIPA1L1 SEC24B CCSER1 | 1.21e-05 | 818 | 173 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 1.69e-05 | 137 | 173 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | KIF26B EYA1 SIX4 RUNX1T1 CTTNBP2NL SALL1 SIPA1L1 TBXT MTCL1 CDHR4 | 3.19e-05 | 243 | 173 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | RALGAPA1 RARB COL17A1 MAP1B SZT2 KIF26B SALL4 EYA1 SIX4 RUNX1T1 CTTNBP2NL SETDB1 SALL1 KCND3 TP63 SIPA1L1 TBXT MTCL1 CDHR4 | 3.33e-05 | 806 | 173 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 3.39e-05 | 75 | 173 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | TBX15 COL17A1 KIF26B PUM2 SALL4 EYA1 RUNX2 RUNX1T1 RUNX3 PRDM1 SYT16 SALL1 TP63 | 5.27e-05 | 429 | 173 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TBX15 TANC2 COL17A1 KIF26B PUM2 SALL4 CHD1 EYA1 SIX4 RUNX2 RUNX1T1 RUNX3 CTTNBP2NL PRDM1 SYT16 SALL1 DLC1 TP63 RPRD2 | 5.44e-05 | 836 | 173 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_100 | 7.35e-05 | 86 | 173 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_100 | 8.36e-05 | 11 | 173 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_200 | 1.01e-04 | 91 | 173 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_100 | 1.11e-04 | 12 | 173 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_100_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | RARB COL17A1 MAP1B KIF26B EYA1 SIX4 RUNX1T1 CTTNBP2NL SALL1 TP63 SIPA1L1 MTCL1 | 1.33e-04 | 407 | 173 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | RARB COL17A1 MAP1B KIF26B EYA1 RUNX1T1 SETDB1 SALL1 DLC1 KCND3 TP63 MTCL1 | 1.36e-04 | 408 | 173 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#3_top-relative-expression-ranked_500 | 2.00e-04 | 103 | 173 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.11e-04 | 196 | 173 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | GPC1 MAP1B DTNA TEDC2 ZDHHC5 SALL4 CHD1 CBARP EYA1 SIX4 PRR12 KANK1 SALL1 AMOT STARD3 LRRC56 UNKL IRS2 DTX2 PIP4P2 WNK2 CCSER1 | 2.69e-04 | 1187 | 173 | 22 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_100 | 2.75e-04 | 16 | 173 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | KIF26B SALL4 CHD1 SYNPO EYA1 RUNX1T1 RUNX3 CTTNBP2NL PRDM1 SYT16 SALL1 | 2.77e-04 | 377 | 173 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 3.05e-04 | 72 | 173 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TANC2 RALGAPA1 RARB MAP1B PUM2 SALL4 CHD1 MED1 WNK1 DLC1 SEC24B | 3.31e-04 | 385 | 173 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | COL17A1 KIF26B SALL4 EYA1 RUNX2 RUNX1T1 RUNX3 CTTNBP2NL PRDM1 SALL1 TP63 | 3.69e-04 | 390 | 173 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.16e-04 | 118 | 173 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 4.17e-04 | 165 | 173 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 4.18e-04 | 217 | 173 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_100 | 4.42e-04 | 78 | 173 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200 | 4.98e-04 | 170 | 173 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_500 | 5.65e-04 | 125 | 173 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | COL17A1 MAP1B KIF26B SALL4 CHD1 SYNPO EYA1 RUNX2 RUNX1T1 RUNX3 CTTNBP2NL PRDM1 SYT16 SALL1 DLC1 TP63 | 5.71e-04 | 769 | 173 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.96e-04 | 229 | 173 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | GPC1 MAP1B DTNA PPM1E SALL4 INPP5F SIX3 SALL1 MAST1 ATP2B2 WNK2 CCSER1 | 6.14e-04 | 482 | 173 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_200 | 6.35e-04 | 21 | 173 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 6.55e-04 | 178 | 173 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_500 | ANK2 KIF26B PPFIA2 SALL4 EYA1 SIX4 RUNX1T1 SYT16 SALL1 RPRD2 CCSER1 | 7.39e-04 | 424 | 173 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | RARB MAP1B KIF26B SALL4 EYA1 CSMD3 SETDB1 DLC1 TP63 RPRD2 CCSER1 | 7.83e-04 | 427 | 173 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | RARB KIF26B MUC16 MUC5B EYA1 RUNX2 TMEM71 DTX2 MUC4 MUC5AC WNK2 SLC4A11 | 2.88e-11 | 198 | 178 | 12 | af07a970afaa435c6433bb5c1cbff4c67af350c7 |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | COL17A1 MUC16 MUC5B MUC17 INAVA MUC3A MUC4 MUC5AC PDE11A CCSER1 | 3.65e-09 | 183 | 178 | 10 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.54e-08 | 167 | 178 | 9 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.61e-08 | 179 | 178 | 9 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.61e-08 | 179 | 178 | 9 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.84e-08 | 180 | 178 | 9 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.84e-08 | 180 | 178 | 9 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 5.58e-08 | 183 | 178 | 9 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | Club|World / shred by cell class for parenchyma | 7.70e-08 | 190 | 178 | 9 | 1974d559d7fee6cb68065b18af8bd38b64910622 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.20e-08 | 194 | 178 | 9 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 9.61e-08 | 195 | 178 | 9 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.61e-08 | 195 | 178 | 9 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.00e-07 | 196 | 178 | 9 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-07 | 198 | 178 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 198 | 178 | 9 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-07 | 200 | 178 | 9 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.31e-07 | 164 | 178 | 8 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.97e-07 | 173 | 178 | 8 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.91e-07 | 177 | 178 | 8 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.91e-07 | 177 | 178 | 8 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 6.43e-07 | 179 | 178 | 8 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 7.92e-07 | 184 | 178 | 8 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.92e-07 | 184 | 178 | 8 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.59e-07 | 186 | 178 | 8 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.31e-07 | 188 | 178 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 9.69e-07 | 189 | 178 | 8 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 9.69e-07 | 189 | 178 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-06 | 190 | 178 | 8 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-06 | 190 | 178 | 8 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 1.01e-06 | 190 | 178 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.01e-06 | 190 | 178 | 8 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.01e-06 | 190 | 178 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.05e-06 | 191 | 178 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.05e-06 | 191 | 178 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.09e-06 | 192 | 178 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-G_(Club-Clara_cells)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.09e-06 | 192 | 178 | 8 | c7c232545fad8ad327ab94bd0def8dc5daacd03d | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.13e-06 | 193 | 178 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-06 | 193 | 178 | 8 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-06 | 196 | 178 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 196 | 178 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 1.27e-06 | 196 | 178 | 8 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 198 | 178 | 8 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-06 | 198 | 178 | 8 | a54ae5275a510b49d7629f0908817a0c5f05020e | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 198 | 178 | 8 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 198 | 178 | 8 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 198 | 178 | 8 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-06 | 198 | 178 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.37e-06 | 198 | 178 | 8 | 34997e3896d0893fbe51bfb0d4660ccaca1c975e | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 198 | 178 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.37e-06 | 198 | 178 | 8 | 686eda427b075e788de38149eae82faf19bd5704 | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 198 | 178 | 8 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-06 | 198 | 178 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Club_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-06 | 138 | 178 | 7 | 133015953fc660d00339f47b415da5e9872313a2 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.48e-06 | 200 | 178 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-06 | 200 | 178 | 8 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | COVID-19_Mild-Neu_0|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 5.35e-06 | 63 | 178 | 5 | 1ab77b6f098686bc168427159282bbf3538d4292 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.42e-06 | 169 | 178 | 7 | 40b557549fe08c5dc9dba359af35993d68d1640a | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.81e-06 | 175 | 178 | 7 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.81e-06 | 175 | 178 | 7 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.80e-06 | 182 | 178 | 7 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 186 | 178 | 7 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.01e-05 | 186 | 178 | 7 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 187 | 178 | 7 | bde6b90955423eab6a91a0abe75d0a95a1f5330a | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.05e-05 | 187 | 178 | 7 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.09e-05 | 188 | 178 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.09e-05 | 188 | 178 | 7 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.09e-05 | 188 | 178 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.12e-05 | 189 | 178 | 7 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 189 | 178 | 7 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 189 | 178 | 7 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 190 | 178 | 7 | e5625feb21915d4545cfad2659745ef180efcb1f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.16e-05 | 190 | 178 | 7 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 1.17e-05 | 126 | 178 | 6 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 192 | 178 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.25e-05 | 192 | 178 | 7 | b204ef6e05170855259b902829a1700094eb9159 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-05 | 192 | 178 | 7 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 128 | 178 | 6 | cfc73cb803ba50a4a8709e19e70e1e399118c849 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 193 | 178 | 7 | 9a6c5b7c8e88cf7a261f8e052df1709d2c0a91f0 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 193 | 178 | 7 | c9e3fefa8d68d0e2b954f85ce37813185ff98d84 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.29e-05 | 193 | 178 | 7 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.29e-05 | 193 | 178 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | 85c5d07189eb7bb413f708a3ca40de08af3cb106 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | fad22d5cf62016cad979e6943e357106d8d2a4b4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 195 | 178 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 195 | 178 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.42e-05 | 196 | 178 | 7 | 3fd5567ea14193181929134c377e8a38fb4f47fd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-05 | 196 | 178 | 7 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 197 | 178 | 7 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 198 | 178 | 7 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | PCW_13-14-Hematologic_Myeloid|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 198 | 178 | 7 | d42fce8e547dc97f3cf144ab65483a1b11ace267 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.52e-05 | 198 | 178 | 7 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-05 | 198 | 178 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-05 | 198 | 178 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 198 | 178 | 7 | 898be90c906ebc806a764ae6c21bbf84649b6b30 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-05 | 199 | 178 | 7 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-05 | 199 | 178 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-05 | 199 | 178 | 7 | f5c3561744e2a0e7716657cb521acb1d8f054b41 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.57e-05 | 199 | 178 | 7 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | 1b527bebbca1ef8c52449e40beb9358e37494e04 | |
| Drug | Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; PC3; HT_HG-U133A | ATXN2L ANK2 DTNA FRMPD1 PASK NCOR2 KCNB1 KCND3 TP63 MUC5AC MUC6 PDE11A | 5.17e-08 | 198 | 177 | 12 | 6652_UP |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | ATXN2L ELOA DTNA AMBRA1 WNK1 MAP3K1 KIDINS220 SIGLEC7 KMT2A RAPGEF2 SRRM2 | 3.88e-07 | 195 | 177 | 11 | 6159_DN |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A | DTNA TTLL5 INO80D NCOR2 KLHL25 NFATC3 KCND3 CD34 RAPGEF2 MUC4 MUC5AC | 4.09e-07 | 196 | 177 | 11 | 5974_DN |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; HL60; HT_HG-U133A | ANK2 MAP1B RUNX2 SIX3 INO80D NCOR2 DLC1 KCND3 TP63 CD34 ATP2B2 | 4.30e-07 | 197 | 177 | 11 | 3065_DN |
| Drug | Milrinone [78415-72-2]; Up 200; 19uM; MCF7; HT_HG-U133A | GPC1 FRMPD1 WNK1 INO80D PASK DLC1 MAST4 SIGLEC7 KCND3 SIGLEC1 ATP2B2 | 4.52e-07 | 198 | 177 | 11 | 7210_UP |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; PC3; HT_HG-U133A | RALGAPA1 DTNA TTLL5 AMBRA1 RUNX3 DHRS12 MAST4 NFATC3 KCND3 VAX2 IL6R | 4.52e-07 | 198 | 177 | 11 | 5087_UP |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | RARB DTNA TNS2 PASK SETDB1 KCNB1 UNKL IRS2 TRAPPC9 MAST3 SMG6 | 4.76e-07 | 199 | 177 | 11 | 4297_DN |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.96e-06 | 185 | 177 | 10 | 3893_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A | ATXN2L DTNA MAST2 VPS13D SALL1 SIGLEC7 SRRM2 ATP2B3 MUC6 AMIGO2 | 2.86e-06 | 193 | 177 | 10 | 2682_UP |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | RALGAPA1 TEDC2 TTLL5 AMBRA1 PPFIA3 SETDB1 MAST4 ZNF592 RAPGEF2 SRRM2 | 3.00e-06 | 194 | 177 | 10 | 7098_DN |
| Drug | clozapine; Up 200; 10uM; PC3; HT_HG-U133A | RARB PPM1E FRMPD1 RUNX1T1 RUNX3 SALL1 CELSR3 ATP2B2 MUC6 TRAPPC9 | 3.29e-06 | 196 | 177 | 10 | 4453_UP |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | GPC1 PCGF2 MAP1B DTNA PPFIA3 MAST4 NFATC3 KMT2A VAX2 TRAPPC9 | 3.44e-06 | 197 | 177 | 10 | 7431_DN |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | HNF1A HTR5A SZT2 RUNX2 NCOR2 KIDINS220 KCND3 KMT2A MAP3K13 ATP2B3 | 3.44e-06 | 197 | 177 | 10 | 4266_UP |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | TTLL5 PROSER1 PPFIA3 INO80D PASK VPS13D KIDINS220 RAPGEF2 MAST3 SMG6 | 3.44e-06 | 197 | 177 | 10 | 6360_DN |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A | RALGAPA1 ATXN2L ANK2 FRMPD1 RUNX3 KIDINS220 KLHL25 DLC1 CD34 MUC6 | 3.60e-06 | 198 | 177 | 10 | 4695_UP |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.60e-06 | 198 | 177 | 10 | 6790_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | TEDC2 AMBRA1 SYNPO IGFLR1 RUNX3 WNK1 PASK RAPGEF2 SRRM2 TNS1 | 3.60e-06 | 198 | 177 | 10 | 6287_DN |
| Drug | Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.60e-06 | 198 | 177 | 10 | 7322_UP | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 3.76e-06 | 199 | 177 | 10 | 3381_DN | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | ATXN2L COL17A1 SZT2 ZC3H13 NCOR2 VPS13D SIGLEC7 ULK1 TNS1 SMAD1 | 3.76e-06 | 199 | 177 | 10 | 3287_UP |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A | 3.76e-06 | 199 | 177 | 10 | 4539_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | ATXN2L PPFIA3 MAST2 INO80D DLC1 MAST4 EHMT1 IRS2 TNS1 PDE11A | 3.76e-06 | 199 | 177 | 10 | 5540_UP |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; PC3; HT_HG-U133A | ATXN2L COL17A1 DTNA SIX3 MAST2 DHRS12 TP63 MAP3K13 TNS1 PDE11A | 3.76e-06 | 199 | 177 | 10 | 3702_UP |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | POU4F2 RUNX3 NCOR2 DHRS12 KLHL25 MAST4 NFATC3 KCND3 ATP2B2 SMAD1 | 3.76e-06 | 199 | 177 | 10 | 5485_UP |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A | COL17A1 ANK2 RUNX1T1 MAP3K1 KIDINS220 KLHL25 SALL1 TNS1 MUC6 IL6R | 3.93e-06 | 200 | 177 | 10 | 3760_UP |
| Drug | aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A | GPC1 ATXN2L PCGF2 FRMPD1 TNS2 SIX3 MAP3K1 KIDINS220 KCND3 TRAPPC9 | 3.93e-06 | 200 | 177 | 10 | 2664_DN |
| Drug | 15d-PGJ2; Up 200; 10uM; PC3; HT_HG-U133A | 1.38e-05 | 183 | 177 | 9 | 4455_UP | |
| Drug | carbidine | 1.42e-05 | 40 | 177 | 5 | CID000065684 | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; HL60; HG-U133A | PCGF2 DTNA MAST2 VPS13D KIDINS220 SIGLEC7 DCLRE1C RAPGEF2 TRAPPC9 | 1.86e-05 | 190 | 177 | 9 | 1990_DN |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.86e-05 | 190 | 177 | 9 | 4362_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.02e-05 | 192 | 177 | 9 | 5216_UP | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.11e-05 | 193 | 177 | 9 | 2764_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 2.20e-05 | 194 | 177 | 9 | 433_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 7135_UP | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 4533_DN | |
| Drug | Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 4742_DN | |
| Drug | PF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 6379_UP | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 3272_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | 2.38e-05 | 196 | 177 | 9 | 6182_DN | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A | 2.38e-05 | 196 | 177 | 9 | 4291_UP | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.38e-05 | 196 | 177 | 9 | 3144_UP | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.38e-05 | 196 | 177 | 9 | 5111_UP | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 6964_UP | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 4137_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 4764_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 3473_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; PC3; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 6623_DN | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A | SZT2 AMBRA1 MAP3K1 NCOR2 KIDINS220 KLHL25 SIGLEC7 NFATC3 CARF | 2.48e-05 | 197 | 177 | 9 | 3304_UP |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 5619_UP | |
| Drug | Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; PC3; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 4014_UP | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 5001_UP | |
| Drug | Arecoline hydrobromide [300-08-3]; Down 200; 17uM; MCF7; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 2657_DN | |
| Drug | Artemisinin [63968-64-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | PCGF2 TTLL5 AMBRA1 SLC10A3 IKZF5 MACO1 SIPA1L1 MTCL1 TRAPPC9 | 2.58e-05 | 198 | 177 | 9 | 7007_DN |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; PC3; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 4214_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; MCF7; HT_HG-U133A | ZC3H13 TTLL5 AMBRA1 C11orf24 PPFIA3 MAP3K1 TBX19 SIPA1L1 SRRM2 | 2.58e-05 | 198 | 177 | 9 | 6502_DN |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 6630_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 4592_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 4316_UP | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; HL60; HT_HG-U133A | GPC1 RALGAPA1 PCGF2 NCOR2 SIGLEC7 SIPA1L1 SRRM2 ATP2B3 SMAD1 | 2.68e-05 | 199 | 177 | 9 | 2985_UP |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.68e-05 | 199 | 177 | 9 | 3249_UP | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; PC3; HT_HG-U133A | 2.68e-05 | 199 | 177 | 9 | 4213_UP | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 2.68e-05 | 199 | 177 | 9 | 5637_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.68e-05 | 199 | 177 | 9 | 6773_UP | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.68e-05 | 199 | 177 | 9 | 2320_UP | |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 2.68e-05 | 199 | 177 | 9 | 7348_UP | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; HL60; HG-U133A | C11orf24 PROSER1 PASK VPS13D SIGLEC7 UNKL RAPGEF2 SRRM2 TNS1 | 2.79e-05 | 200 | 177 | 9 | 2018_DN |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.79e-05 | 200 | 177 | 9 | 5570_UP | |
| Drug | D-8 (pharmaceutical) | 3.75e-05 | 9 | 177 | 3 | CID000107261 | |
| Drug | 1sqc | 5.33e-05 | 10 | 177 | 3 | CID000444279 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.21e-05 | 172 | 177 | 8 | 1072_DN | |
| Drug | 2,5-dimethylquinone | 7.28e-05 | 11 | 177 | 3 | CID000008718 | |
| Drug | butylate | 8.26e-05 | 30 | 177 | 4 | CID000016181 | |
| Drug | lomustine; Down 200; 100uM; PC3; HT_HG-U133A | 8.54e-05 | 180 | 177 | 8 | 7094_DN | |
| Drug | 1vyq | 9.65e-05 | 12 | 177 | 3 | CID004369390 | |
| Drug | Ro 46861 | 9.65e-05 | 12 | 177 | 3 | CID000003128 | |
| Drug | Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 185 | 177 | 8 | 3536_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.07e-04 | 186 | 177 | 8 | 3768_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A | 1.20e-04 | 189 | 177 | 8 | 410_DN | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.24e-04 | 190 | 177 | 8 | 4144_UP | |
| Drug | 8-hydroxycoumarin | 1.25e-04 | 13 | 177 | 3 | CID000122783 | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.29e-04 | 191 | 177 | 8 | 4283_DN | |
| Drug | 0393-0188; Up 200; 10uM; PC3; HT_HG-U133A | 1.34e-04 | 192 | 177 | 8 | 7536_UP | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.39e-04 | 193 | 177 | 8 | 3197_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.39e-04 | 193 | 177 | 8 | 4322_UP | |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A | 1.39e-04 | 193 | 177 | 8 | 4503_UP | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.39e-04 | 193 | 177 | 8 | 6717_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.39e-04 | 193 | 177 | 8 | 4712_UP | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.39e-04 | 193 | 177 | 8 | 1817_UP | |
| Drug | indomethacin, USP; Up 200; 20uM; MCF7; HG-U133A | 1.39e-04 | 193 | 177 | 8 | 262_UP | |
| Drug | 0297417-0002B [362658-29-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.44e-04 | 194 | 177 | 8 | 6895_DN | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A | 1.44e-04 | 194 | 177 | 8 | 4310_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.44e-04 | 194 | 177 | 8 | 3173_UP | |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 6662_UP | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; HL60; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 2705_DN | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 5385_UP | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; HL60; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 2940_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 5261_UP | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 2956_DN | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 4232_UP | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 2875_UP | |
| Disease | cholangiocarcinoma (is_marker_for) | 9.89e-08 | 64 | 173 | 7 | DOID:4947 (is_marker_for) | |
| Disease | migraine disorder | KIF26B AMBRA1 POU4F3 EYA1 NCOR2 ZNF106 KANK1 ATRIP DCLRE1C CARF EHMT1 ATP2B1 SMG6 | 2.12e-07 | 357 | 173 | 13 | MONDO_0005277 |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.96e-06 | 5 | 173 | 3 | DOID:3030 (is_marker_for) | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 3.91e-06 | 6 | 173 | 3 | DOID:0050429 (implicated_via_orthology) | |
| Disease | sensory peripheral neuropathy, remission | 9.26e-06 | 23 | 173 | 4 | EFO_0009785, MONDO_0002321 | |
| Disease | Colorectal Carcinoma | RARB ANK2 HTR5A MAP1B PPM1E CHD1 CORO1B RUNX1T1 WNK1 CSMD3 KMT2C DLC1 SIGLEC7 KCND3 TP63 | 1.81e-05 | 702 | 173 | 15 | C0009402 |
| Disease | keratoconjunctivitis (is_marker_for) | 1.02e-04 | 3 | 173 | 2 | DOID:9368 (is_marker_for) | |
| Disease | FEV/FEC ratio | RARB EYA1 RUNX2 RUNX1T1 RUNX3 CTTNBP2NL MAP3K1 PRR12 ZNF106 KANK1 KLHL25 DLC1 KCNN3 MTCL1 CSMD1 TNS1 ATP2B1 CDHR4 SMG6 | 1.15e-04 | 1228 | 173 | 19 | EFO_0004713 |
| Disease | Limb Deformities, Congenital | 1.27e-04 | 17 | 173 | 3 | C0206762 | |
| Disease | obsolete_red blood cell distribution width | HNF1A POU4F3 IGFLR1 FREM3 WNK1 PLEKHG5 GMNN MAP3K1 MAST4 MUC17 CD33 MAST1 CD68 IRS2 MUC4 ATP2B3 TRAPPC9 IL6R SMAD1 MAST3 | 1.32e-04 | 1347 | 173 | 20 | EFO_0005192 |
| Disease | neutrophil count | TBX15 HNF1A DCLRE1B VWA7 RUNX3 MAST2 CTTNBP2NL TBX19 DHRS12 KIDINS220 SALL1 KCND3 CD33 STARD3 KCNN3 RPRD2 PRKDC TNS3 HTT SMG6 | 1.85e-04 | 1382 | 173 | 20 | EFO_0004833 |
| Disease | neuroimaging measurement | ATXN2L MAP1B SZT2 KIF26B ZDHHC5 RUNX2 RUNX1T1 MAP3K1 ZNF106 MAST4 TP63 RAPGEF2 TNS1 WNK2 HTT CRTC2 SMG6 | 1.95e-04 | 1069 | 173 | 17 | EFO_0004346 |
| Disease | Liver carcinoma | HNF1A TEDC2 MED1 RUNX3 GMNN KMT2C CELSR3 CD34 KMT2A IRS2 CSMD1 | 2.14e-04 | 507 | 173 | 11 | C2239176 |
| Disease | Metastatic melanoma | 2.87e-04 | 54 | 173 | 4 | C0278883 | |
| Disease | Hereditary Diffuse Gastric Cancer | 3.53e-04 | 293 | 173 | 8 | C1708349 | |
| Disease | Stomach Neoplasms | 3.86e-04 | 297 | 173 | 8 | C0038356 | |
| Disease | insulin resistance | 4.04e-04 | 59 | 173 | 4 | EFO_0002614 | |
| Disease | Malignant neoplasm of stomach | 4.13e-04 | 300 | 173 | 8 | C0024623 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 4.59e-04 | 61 | 173 | 4 | DOID:3587 (is_marker_for) | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 5.05e-04 | 6 | 173 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | blood manganese measurement | 5.22e-04 | 27 | 173 | 3 | EFO_0007581 | |
| Disease | interleukin-6 measurement | 5.29e-04 | 112 | 173 | 5 | EFO_0004810 | |
| Disease | Carcinoma, Granular Cell | 6.20e-04 | 116 | 173 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 6.20e-04 | 116 | 173 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 6.20e-04 | 116 | 173 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 6.20e-04 | 116 | 173 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 6.20e-04 | 116 | 173 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 6.20e-04 | 116 | 173 | 5 | C0001418 | |
| Disease | coronary artery disease | HJV HNF1A MAP1B DCLRE1B RUNX2 MAP3K1 DLC1 MAST4 CARF RPRD2 RAPGEF2 TNS1 ATP2B1 IL6R WNK2 TNS3 SMG6 | 6.87e-04 | 1194 | 173 | 17 | EFO_0001645 |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 7.04e-04 | 7 | 173 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 7.04e-04 | 7 | 173 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | uridine measurement | 8.67e-04 | 32 | 173 | 3 | EFO_0010546 | |
| Disease | Acute Myeloid Leukemia, M1 | 8.70e-04 | 125 | 173 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 8.70e-04 | 125 | 173 | 5 | C1879321 | |
| Disease | common bile duct neoplasm (is_marker_for) | 9.35e-04 | 8 | 173 | 2 | DOID:4608 (is_marker_for) | |
| Disease | myocardial infarction | 1.12e-03 | 350 | 173 | 8 | EFO_0000612 | |
| Disease | immunoglobulin M measurement | 1.20e-03 | 9 | 173 | 2 | EFO_0020466 | |
| Disease | Cleft palate, cleft lip | 1.35e-03 | 279 | 173 | 7 | EFO_0003959, HP_0000175 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.40e-03 | 139 | 173 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | lactose measurement | 1.49e-03 | 10 | 173 | 2 | EFO_0010507 | |
| Disease | dry eye syndrome (is_marker_for) | 1.49e-03 | 10 | 173 | 2 | DOID:10140 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 1.49e-03 | 10 | 173 | 2 | DOID:10754 (is_marker_for) | |
| Disease | brain measurement, neuroimaging measurement | ATXN2L KIF26B RUNX2 RUNX1T1 MAP3K1 MAST4 CARF TNS1 WNK2 SMG6 | 1.58e-03 | 550 | 173 | 10 | EFO_0004346, EFO_0004464 |
| Disease | depressive symptom measurement, response to antidepressant | 1.81e-03 | 88 | 173 | 4 | EFO_0007006, GO_0036276 | |
| Disease | Congenital Abnormality | 1.82e-03 | 11 | 173 | 2 | C0000768 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 1.82e-03 | 11 | 173 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | pulmonary fibrosis | 1.82e-03 | 11 | 173 | 2 | EFO_0009448 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 1.82e-03 | 11 | 173 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | ankylosing spondylitis | 2.05e-03 | 91 | 173 | 4 | EFO_0003898 | |
| Disease | hypertrophic cardiomyopathy | 2.14e-03 | 92 | 173 | 4 | EFO_0000538 | |
| Disease | Mitral valve prolapse, response to surgery | 2.17e-03 | 12 | 173 | 2 | EFO_0009951, HP_0001634 | |
| Disease | triacylglycerol 44:1 measurement | 2.17e-03 | 12 | 173 | 2 | EFO_0010399 | |
| Disease | cholesteryl ester 24:5 measurement | 2.17e-03 | 12 | 173 | 2 | EFO_0021448 | |
| Disease | heart rate | 2.18e-03 | 225 | 173 | 6 | EFO_0004326 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.19e-03 | 154 | 173 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | Neurodevelopmental Disorders | 2.22e-03 | 93 | 173 | 4 | C1535926 | |
| Disease | Craniofacial Abnormalities | 2.31e-03 | 156 | 173 | 5 | C0376634 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 2.35e-03 | 45 | 173 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 2.35e-03 | 45 | 173 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | cortical thickness | EYA1 RUNX2 RUNX1T1 MAST2 MAP3K1 ZNF106 VPS13D DLC1 MAST4 CD68 KMT2A MTCL1 TNS1 WNK2 SMG6 | 2.41e-03 | 1113 | 173 | 15 | EFO_0004840 |
| Disease | dimethylglycine measurement | 2.50e-03 | 46 | 173 | 3 | EFO_0010476 | |
| Disease | interleukin 6 receptor subunit alpha measurement | 2.55e-03 | 13 | 173 | 2 | EFO_0008187 | |
| Disease | gastric ulcer (implicated_via_orthology) | 2.97e-03 | 14 | 173 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | triacylglycerol 46:2 measurement | 2.97e-03 | 14 | 173 | 2 | EFO_0010402 | |
| Disease | Arthritis, Psoriatic | 2.97e-03 | 14 | 173 | 2 | C0003872 | |
| Disease | sulfate measurement | 2.97e-03 | 14 | 173 | 2 | EFO_0007864 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.99e-03 | 49 | 173 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | neurotic disorder | 3.00e-03 | 101 | 173 | 4 | EFO_0004257 | |
| Disease | pancreatic cancer (is_marker_for) | 3.00e-03 | 101 | 173 | 4 | DOID:1793 (is_marker_for) | |
| Disease | Tourette syndrome | 3.17e-03 | 50 | 173 | 3 | EFO_0004895 | |
| Disease | myeloid cell surface antigen CD33 measurement | 3.41e-03 | 15 | 173 | 2 | EFO_0008238 | |
| Disease | Proteinuria | 3.41e-03 | 15 | 173 | 2 | HP_0000093 | |
| Disease | hepatoblastoma (is_marker_for) | 3.41e-03 | 15 | 173 | 2 | DOID:687 (is_marker_for) | |
| Disease | hepcidin:transferrin saturation ratio | 3.41e-03 | 15 | 173 | 2 | EFO_0007902 | |
| Disease | Leukemia, Myelocytic, Acute | 3.61e-03 | 173 | 173 | 5 | C0023467 | |
| Disease | reticulocyte measurement | EYA1 RUNX3 MAP3K1 SIGLEC7 CD33 MACO1 MAST1 IRS2 SIGLEC1 TNS1 ATP2B1 SLC4A11 TNS3 SMG6 | 3.78e-03 | 1053 | 173 | 14 | EFO_0010700 |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 3.89e-03 | 16 | 173 | 2 | EFO_0008297 | |
| Disease | Ischemic stroke, fibrinogen measurement | 4.16e-03 | 55 | 173 | 3 | EFO_0004623, HP_0002140 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 4.37e-03 | 56 | 173 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | triacylglycerol 48:1 measurement | 4.39e-03 | 17 | 173 | 2 | EFO_0010404 | |
| Disease | phosphatidylcholine 40:6 measurement | 4.39e-03 | 17 | 173 | 2 | EFO_0010389 | |
| Disease | otitis media (biomarker_via_orthology) | 4.39e-03 | 17 | 173 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.39e-03 | 17 | 173 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | apolipoprotein A 1 measurement | HNF1A RARB PUM2 EYA1 NCOR2 DLC1 NFATC3 MUC17 STARD3 KMT2A SMG6 CCSER1 | 4.43e-03 | 848 | 173 | 12 | EFO_0004614 |
| Disease | large artery stroke | 4.48e-03 | 113 | 173 | 4 | EFO_0005524 | |
| Disease | idiopathic pulmonary fibrosis | 4.59e-03 | 57 | 173 | 3 | EFO_0000768 | |
| Disease | fibrinogen measurement, factor VII measurement | 4.82e-03 | 58 | 173 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | lung disease severity measurement | 5.21e-03 | 118 | 173 | 4 | EFO_0007744 | |
| Disease | diffuse plaque measurement | TBX15 ANK2 KIF26B SALL4 CSMD3 NCOR2 DLC1 MAST4 TNS1 PDE11A CCSER1 | 5.28e-03 | 758 | 173 | 11 | EFO_0010699 |
| Disease | Chronic myeloproliferative disorder | 5.47e-03 | 19 | 173 | 2 | C1292778 | |
| Disease | cortical surface area measurement | TANC2 ATXN2L KIF26B ZC3H13 FAM117B EYA1 RUNX1T1 SIX3 MAST2 MAP3K1 ZNF106 MAST4 MTCL1 TNS1 WNK2 SMG6 | 5.83e-03 | 1345 | 173 | 16 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGEASSATTPHPATS | 186 | Q8N350 | |
| CSPTLHPGLSTSSSV | 266 | Q9UMD9 | |
| TSHSPTPGKVSSPLS | 546 | Q9P2B4 | |
| LPAHTTLSVNSAGSP | 411 | Q86US8 | |
| ASLASPSLRTSHSGP | 346 | P50406 | |
| QPHSPTSSLTSGGSL | 306 | Q4VCS5 | |
| SGLLSHSSTLTGSPI | 796 | Q4VCS5 | |
| PSTPLLSAHSKTGSR | 846 | Q4VCS5 | |
| TLRGTSSSISSPHFP | 211 | Q96PZ7 | |
| LSGPQIPSSLFSTTH | 2181 | Q7Z407 | |
| LHSPPTTSTSALNSL | 381 | Q96Q42 | |
| SPGVLSSTPDHSFSL | 166 | P18848 | |
| PGSSHLGAPASTTTA | 421 | Q9BR76 | |
| HSSILSPGPASDASA | 441 | Q86SJ2 | |
| HDSLPSSPSSSNTVG | 26 | Q9C0I3 | |
| AHTSSPQPSTSRGLL | 1201 | Q9C0C7 | |
| SPLSHSSKGTPLLAT | 481 | Q9H816 | |
| TVLHTGSAPSSSTPF | 946 | O14646 | |
| DAGPSTPHLSTTATI | 631 | A6H8M9 | |
| NKSATSSSPGSPLHS | 1201 | P20020 | |
| SATSSSPGSPIHSLE | 1226 | Q01814 | |
| TSSVFSSSPGSPLHS | 1201 | Q16720 | |
| TSGSHPQAIVSSSTP | 826 | Q8WWM7 | |
| SPHRESLPGLSSTAT | 981 | Q8TDY8 | |
| VATPSSTPGTAHTTK | 2036 | Q9HC84 | |
| RGSTVTPSSIPGTTH | 2086 | Q9HC84 | |
| TPSSIPGTTHTATVL | 2091 | Q9HC84 | |
| TTGTTQHSTPALSSP | 2241 | Q9HC84 | |
| AGTPHVSTTATTPTV | 2491 | Q9HC84 | |
| GSVATPSSTPGTAHT | 2591 | Q9HC84 | |
| STVTPSSALGTTHTP | 2731 | Q9HC84 | |
| GSVATPSSTPGTAHT | 3291 | Q9HC84 | |
| STVTPSSALGTTHTP | 3431 | Q9HC84 | |
| ATAGTPHVSTTATTP | 3746 | Q9HC84 | |
| ATPSSTPGTAHTTKV | 3851 | Q9HC84 | |
| GSTVTPSSVPGTTHT | 3901 | Q9HC84 | |
| ITEPSTGTSHTPAAT | 4041 | Q9HC84 | |
| SPGTTTPGHTTATSR | 4081 | Q9HC84 | |
| AGTPHVSTTATTPTV | 4476 | Q9HC84 | |
| GSVATPSSTPGTAHT | 4576 | Q9HC84 | |
| SSSGNTAEHSPSISP | 426 | P10826 | |
| RSSHGSPPTLSTLTL | 11 | Q6ZVN8 | |
| SPLPHLTESSSFLST | 901 | Q9Y4B5 | |
| TPPPSLSSHGSSSSL | 636 | Q8TB72 | |
| PVLTQPSSHSASSGA | 21 | A0A0A0MRZ9 | |
| GSPSPKTERHSTLSS | 1821 | Q01484 | |
| SQGPSTATHSPATTS | 101 | P34810 | |
| SHSPLPAGGLTTTTT | 101 | Q9BY79 | |
| IHPTGTLTSESSESP | 821 | Q8WXI7 | |
| STSISHLPTGTTSPT | 3256 | Q8WXI7 | |
| EASSSHSNSPPLTIS | 6136 | Q8WXI7 | |
| SSPVHLTSLPTSGLV | 6536 | Q8WXI7 | |
| TPSSPGSTHLLQSSK | 10186 | Q8WXI7 | |
| GAATSTTVPTLTHSP | 11751 | Q8WXI7 | |
| GLTSPQTETHTLSPS | 946 | Q99102 | |
| TDASSVSTGHATPLP | 996 | Q99102 | |
| VTSPSSVSTGHTTPL | 1011 | Q99102 | |
| SVSTGHTTPLPVTDT | 1016 | Q99102 | |
| SSESTGHVTPLPVTS | 1031 | Q99102 | |
| GHVTPLPVTSFSSAS | 1036 | Q99102 | |
| PLPVTDTSSASTGHV | 1056 | Q99102 | |
| DTSSASTGHVTPLPV | 1061 | Q99102 | |
| STGHVTPLPVTSLSS | 1066 | Q99102 | |
| SSVSTGHTTPLPVTD | 1111 | Q99102 | |
| GHTTPLPVTDTSSAS | 1116 | Q99102 | |
| TSSASTGHATPLPVT | 1206 | Q99102 | |
| TSLPVTIPSAASTGH | 1231 | Q99102 | |
| ASTGHTTPLPVTDTS | 1241 | Q99102 | |
| STGHATPLPVTSLSS | 1306 | Q99102 | |
| PVTDASSVSTGHTTP | 1346 | Q99102 | |
| TPLPVTSPSSASTGH | 1391 | Q99102 | |
| TSPSSASTGHATPLL | 1396 | Q99102 | |
| SASTGHATPLPVTDA | 1416 | Q99102 | |
| LPVTIPSAASTGHTT | 1441 | Q99102 | |
| TGHTTPLPVTDTSSA | 1451 | Q99102 | |
| SSASTGHATPLPVTS | 1511 | Q99102 | |
| GHATPLPVTSLSSAS | 1516 | Q99102 | |
| TPLPVTDASSVSTGH | 1551 | Q99102 | |
| TDASSVSTGHTTPLP | 1556 | Q99102 | |
| VTSPSSASTGHTTPL | 1571 | Q99102 | |
| SASTGHTTPLPVTDT | 1576 | Q99102 | |
| LPVTSPSSASTGHTT | 1601 | Q99102 | |
| PSSASTGHTTPLPVT | 1606 | Q99102 | |
| TGHTTPLPVTDTSSA | 1611 | Q99102 | |
| TPLPVTNASSLSTGH | 1631 | Q99102 | |
| ATPLHVTSPSSASTG | 1646 | Q99102 | |
| VTSPSSASTGHATPL | 1651 | Q99102 | |
| SASTGHATPLPVTST | 1656 | Q99102 | |
| SSASTGHATPLPVTG | 1671 | Q99102 | |
| GHATPLPVTGLSSAT | 1676 | Q99102 | |
| VTSPSSASTGHASPL | 1731 | Q99102 | |
| TAHATPLPVTGLSSA | 1771 | Q99102 | |
| LPVTIPSSASSGHTT | 1841 | Q99102 | |
| PSSASSGHTTSLPVT | 1846 | Q99102 | |
| PLPVTSPSSASSGHT | 1936 | Q99102 | |
| SPSSASSGHTTPLPV | 1941 | Q99102 | |
| SSGHTTPLPVTDASS | 1946 | Q99102 | |
| TDASSVPTGHATSLP | 1956 | Q99102 | |
| SSVSTGHATPLPVTD | 1991 | Q99102 | |
| GHATPLPVTDTSSVS | 1996 | Q99102 | |
| DTSSASTGHATPLPV | 2181 | Q99102 | |
| STGHATPLPVTDTSS | 2186 | Q99102 | |
| VTSPSSASTGHAIPL | 2211 | Q99102 | |
| VTSPSSASTGHATPL | 2291 | Q99102 | |
| SSASTGHATPLPVTS | 2311 | Q99102 | |
| GHATPLPVTSLSSAS | 2316 | Q99102 | |
| SASSGHTTPLPVTDA | 2376 | Q99102 | |
| TNVSSASTGHATPLP | 2436 | Q99102 | |
| ASTGHATPLPVTSTS | 2441 | Q99102 | |
| PGTDTSSVSTGHTTP | 2466 | Q99102 | |
| RLPVTSPSSASTGHT | 2496 | Q99102 | |
| SPSSASTGHTTPLPV | 2501 | Q99102 | |
| TSAASTGHATPLPVT | 2566 | Q99102 | |
| TGHATPLPVTSTSSA | 2571 | Q99102 | |
| TPLPVTSPSSASTGH | 2671 | Q99102 | |
| TSPSSASTGHATSLP | 2676 | Q99102 | |
| TPLPVTDTSSASTGH | 2751 | Q99102 | |
| TDTSSASTGHATPLP | 2756 | Q99102 | |
| ASTGHATPLPVTNTS | 2761 | Q99102 | |
| SSASTGHTTPLPVTD | 2791 | Q99102 | |
| GHTTPLPVTDASSVS | 2796 | Q99102 | |
| FTGHATSLPVTIPSS | 2826 | Q99102 | |
| TSLPVTIPSSASSGH | 2831 | Q99102 | |
| TIPSSASSGHTTPLP | 2836 | Q99102 | |
| ASSGHTTPLPVTDAS | 2841 | Q99102 | |
| SSVSTGHATPLPVTD | 2871 | Q99102 | |
| ASSVSTGHATPLPLT | 2886 | Q99102 | |
| TGHATPLPLTSLSSV | 2891 | Q99102 | |
| TSSASTGHATPLPDT | 2966 | Q99102 | |
| SSASTGHATPLPVTD | 3031 | Q99102 | |
| GHATPLPVTDTSSAS | 3036 | Q99102 | |
| STGHATPLPVTDTSS | 3066 | Q99102 | |
| TPLPVTDTSSASTGH | 3071 | Q99102 | |
| TDTSSASTGHATPLP | 3076 | Q99102 | |
| ASTGHATPLPVTSLS | 3081 | Q99102 | |
| SSASTGHTTPLPVTD | 3111 | Q99102 | |
| GHTTPLPVTDTSSAS | 3116 | Q99102 | |
| TPLPVTSPSSASTGH | 3231 | Q99102 | |
| TSPSSASTGHATSLP | 3236 | Q99102 | |
| ATPLHVTSPSSASTG | 3326 | Q99102 | |
| PVTDTSSVSTGHATP | 3346 | Q99102 | |
| SSVSTGHATPLPVTG | 3351 | Q99102 | |
| VTSPSSASTGHATPL | 3411 | Q99102 | |
| SASTGHATPLPVTST | 3416 | Q99102 | |
| SSASTGHATPVPVTS | 3431 | Q99102 | |
| GHATPVPVTSTSSAS | 3436 | Q99102 | |
| TSSASTGHTTPLPVT | 3446 | Q99102 | |
| TGHTTPLPVTDTSSA | 3451 | Q99102 | |
| TPLPVTSPSSASTGH | 3471 | Q99102 | |
| TTPLHVTIPSSASTG | 3486 | Q99102 | |
| PVTGASSASTGHATP | 3506 | Q99102 | |
| SSASTGHATPLPVTD | 3511 | Q99102 | |
| GHATPLPVTDTSSVS | 3516 | Q99102 | |
| TSSVSTGHATPLPVT | 3526 | Q99102 | |
| TGHATPLPVTSLSSV | 3531 | Q99102 | |
| SSVSTGHATPLPVTD | 3591 | Q99102 | |
| GHATPLPVTDTSSAS | 3596 | Q99102 | |
| SVSTGHATPLPVTDT | 3656 | Q99102 | |
| PLPVTIPSSSSSGHT | 3696 | Q99102 | |
| IPSSSSSGHTTPLPV | 3701 | Q99102 | |
| TPLPVTSTSSVSTGH | 3711 | Q99102 | |
| VTPLHVTSPSSASTG | 3726 | Q99102 | |
| VTSPSSASTGHVTPL | 3731 | Q99102 | |
| SASTGHVTPLPVTST | 3736 | Q99102 | |
| ASSVSTGHATPLPVT | 3766 | Q99102 | |
| TGHATPLPVTDASSA | 3771 | Q99102 | |
| PVTDASSASTGHATP | 3826 | Q99102 | |
| SSASTGHATPLPVTI | 3831 | Q99102 | |
| STGHATPLPVTGLSS | 3866 | Q99102 | |
| VSSASTGHATPLPVT | 3926 | Q99102 | |
| TGHATPLPVTSTSSA | 3931 | Q99102 | |
| TPLPVTDTSSVSTGH | 3951 | Q99102 | |
| SASTGHATPLPVTDT | 3976 | Q99102 | |
| PVTDTSSVSTGHATP | 3986 | Q99102 | |
| SSVSTGHATPLPVTS | 3991 | Q99102 | |
| GHATPLPVTSTSSVS | 3996 | Q99102 | |
| TSSVSTGHATPLPVT | 4006 | Q99102 | |
| ASSASTGHATPLPLT | 4086 | Q99102 | |
| TGHATPLPLTSLSSV | 4091 | Q99102 | |
| PVTIPSSASSGHTTS | 4146 | Q99102 | |
| ASSVSTGHGTPLPVT | 4166 | Q99102 | |
| TGHGTPLPVTSTSSA | 4171 | Q99102 | |
| TPLPVTDTSSASTGH | 4191 | Q99102 | |
| TDTSSASTGHATPLP | 4196 | Q99102 | |
| ASTGHATPLPVTDTS | 4201 | Q99102 | |
| SASTGHATPLPVTSL | 4216 | Q99102 | |
| HATPLPVTSLSSVST | 4221 | Q99102 | |
| PVTSLSSVSTGHATP | 4226 | Q99102 | |
| GLLSSTGPSPSSNHT | 1231 | Q6W4X9 | |
| ATSASNHSAPTGTIP | 1471 | Q6W4X9 | |
| THTAPPITPTTSGTS | 1496 | Q6W4X9 | |
| PITPTTSGTSQAHSS | 1501 | Q6W4X9 | |
| PTTLKATGSTHTAPT | 1656 | Q6W4X9 | |
| LPHLSSATTPVSTTN | 2111 | Q6W4X9 | |
| TPSSHLASSTIAFPS | 2236 | Q6W4X9 | |
| SSLTAHGSTPASAPV | 2321 | Q6W4X9 | |
| HGSTPASAPVSSLGT | 2326 | Q6W4X9 | |
| GPTHLTKPTTTSSSE | 1781 | Q9Y618 | |
| PGSTHSTAAELTGPS | 951 | Q96RG2 | |
| PGSTTISGRSSPHST | 1401 | Q9ULH0 | |
| TRSPSLSSHPGLTTT | 531 | Q9UK17 | |
| LLSSSSAPTKSGTHG | 1411 | Q8NEZ4 | |
| SIANPAASTSPSLSH | 16 | P46821 | |
| STSSAHTPSQIASPL | 1731 | P46821 | |
| SGPSELIPSSTFSAH | 76 | Q96GA3 | |
| HTAGATSSLTPSRGP | 206 | Q7Z434 | |
| PSSPHSLTSTLVSLG | 1061 | Q9BY89 | |
| FTPTTLTNGTSHSPT | 71 | Q06455 | |
| HLPPGSSTSGAVSAS | 291 | Q86UW9 | |
| KSSSSRTPLTHALPG | 506 | P35052 | |
| TSTLASPSPPSSGHS | 661 | O75145 | |
| SAAPTSLGPRTTHSS | 181 | P20138 | |
| SPRSVPGSSSQHSAS | 1021 | Q2KJY2 | |
| TRGSLSPEPTHLLSS | 536 | Q8N187 | |
| SSPRSHSATNGSIPS | 331 | Q8N5G2 | |
| HTPISDSPIGVSSTS | 706 | Q9UGI6 | |
| PFGKSTLSSSSPVAH | 721 | Q1X8D7 | |
| ASTSLSTAGGHTVPP | 46 | P09131 | |
| SVGTTHTQSISSPPA | 1671 | Q02505 | |
| PRPSLAGTSSLAHST | 51 | Q9HCR9 | |
| LTSPHSRLSGSSESP | 6 | Q99502 | |
| QPGSSTSSSSHLAKP | 301 | Q5W0B1 | |
| HSPLSSGISTPVTNV | 241 | Q14678 | |
| VSPTGLEPSHSLLST | 351 | P20823 | |
| PTITPPAHTTGTSSS | 136 | Q9UQV4 | |
| LVVSSTHTPSNGPSS | 1336 | P98088 | |
| SSEPSAHTSTPSIGN | 331 | Q9H5V7 | |
| TGLFTKPSISAHPSS | 116 | Q9H7L2 | |
| RSLSSSDSLPGSPTH | 1116 | Q9Y2H9 | |
| ELHNLSSPSPSLSSS | 41 | Q8TDS5 | |
| HSTTTTPVPSIFSGL | 351 | Q86XN7 | |
| TSLPHPSSTAAVLSG | 736 | Q86XN7 | |
| PSHKIGTSLSSLTGS | 696 | Q8WY54 | |
| ATSSSLPSPATPSHG | 271 | P35227 | |
| SESSLGTSHLGTPPA | 786 | O43283 | |
| SLSAGSSPLHSPKIT | 336 | Q58A45 | |
| SQSSGSSATHPISVP | 306 | Q9Y4H2 | |
| SSPSHLLRTPSSAST | 611 | Q9H3D4 | |
| PSLSPATTGALISHE | 2581 | P42858 | |
| PVSPSSLGSDNTSSH | 431 | P08887 | |
| HSPLTSLPSKTGGST | 606 | Q14721 | |
| HTSLAGVFPASPSVS | 396 | Q9H0H3 | |
| PAVSSASTAHPSLGS | 541 | Q6AI39 | |
| PSTGEPTTLSSETHI | 616 | Q96SD1 | |
| DGPSTSSAHLAPVVS | 751 | Q14241 | |
| SLGHPSLSAPALSSS | 386 | Q53ET0 | |
| SGVVPAASSSASTPH | 956 | Q5SYB0 | |
| LLGTVSSPSSSPTHL | 146 | Q6P1L5 | |
| SPSPLLFASHTGSSL | 171 | Q8N1L9 | |
| AGAQTLSPTSHPSSA | 341 | Q8ND61 | |
| PTHLGSATLSSSLSP | 611 | O75417 | |
| SLTTSAAEGAHPSPL | 331 | P51810 | |
| TPSSSHLSSPGALET | 211 | Q9H665 | |
| VSTHLPLATASSSPA | 286 | A0PJE2 | |
| SLSTPSPLETNHSLG | 11 | P47898 | |
| SPTSGSPRGSHSSAL | 76 | Q8IV03 | |
| SSSVPSSPAGSGHTR | 1301 | Q6P0Q8 | |
| LHHSLSSSESLPGSP | 1096 | O60307 | |
| SSSESLPGSPTHSLS | 1101 | O60307 | |
| LSSGESLPGSPTHSL | 1291 | O15021 | |
| SHSVPSSGSPFITRS | 351 | Q9Y4J8 | |
| GHLLSTSLSTPPTTS | 911 | Q53TQ3 | |
| SHSSIAPPTGFTVTG | 996 | Q53TQ3 | |
| PLPRHTSSTDGTITS | 86 | Q12912 | |
| TPTSSASVPGHVTLT | 3351 | Q03164 | |
| SSLVPSPSSSAHSGF | 61 | Q8NAJ2 | |
| PSATTVGTQTLPHSS | 791 | Q8NEL9 | |
| HLLSSSSESPAGTPL | 331 | Q8WXE1 | |
| GVAHTSSPPSTQTLS | 581 | Q8N9H9 | |
| HGSPPLSASASVTVT | 731 | Q9NYQ7 | |
| VQSSSTPLGPHTTAT | 3261 | Q9NYQ7 | |
| HTTATPSATASVLGP | 3271 | Q9NYQ7 | |
| SVLGPSTPRSATSHS | 3281 | Q9NYQ7 | |
| SLSSTPFSSPTLNHA | 386 | Q9C0E4 | |
| SSGSSSTRTPPTANH | 321 | O95487 | |
| ILSSLGSSAPSESHP | 691 | Q5VT52 | |
| PPAHSSSNTIRSGIS | 496 | Q6UVJ0 | |
| TGLHVTPSPSESSSS | 1051 | Q9Y2H2 | |
| SHVPSGPLSSSATSP | 1106 | Q9NSC2 | |
| HANIPSATSSLSPGL | 296 | Q9UJQ4 | |
| PLRTTSTLASSLPGH | 136 | Q9H9B1 | |
| VSSISHPTSPGSSSP | 461 | Q3KP66 | |
| TTTPSTLGSTSLHPV | 61 | P28906 | |
| SPITKHGLSSGSSST | 1156 | Q15648 | |
| SSLASSSPPSGHSTP | 711 | O75334 | |
| SHTLSSLATGASGLP | 261 | Q3SYA9 | |
| PSRPSHTLSSLATGA | 216 | A6NNC1 | |
| GTTPLTSTPVSHTLV | 981 | Q685J3 | |
| DHLTSTTSSPGVIVP | 56 | O75496 | |
| SATTAPSIPSHLSPG | 1466 | Q13233 | |
| GQSRPLSSTHSIPIS | 446 | P0C091 | |
| SHGTASAASPSTSTP | 241 | Q8TC56 | |
| HSTTPLSSTRGTGLP | 316 | Q13950 | |
| STPSPRGSLSTTSHF | 211 | Q13761 | |
| TPVLSLQPSGSDSSH | 541 | Q5T011 | |
| LASPTELPSATHSGQ | 541 | Q8NBS3 | |
| THTTALAGRSPSPAS | 286 | Q9UQ35 | |
| ITSSSSHIISQPPGG | 186 | Q6P5X7 | |
| GSPLSPSAVSHSDST | 481 | Q17RD7 | |
| IVTSSGTTASAPPHS | 111 | Q7L2K0 | |
| LASEPSGTSSQHLVP | 436 | Q8IYG6 | |
| SSLPGHAPGLSLSST | 206 | Q8N3V7 | |
| YSALHSTSPGSSAPI | 26 | Q12837 | |
| SSSVPISHPSALAGT | 156 | Q12837 | |
| PLLSASHSGNVTPTA | 11 | Q8N4L2 | |
| TSSTGTPSPSASSHL | 351 | Q96SF7 | |
| LVSGPLSHSASFSSP | 371 | O43166 | |
| HGSAESPSTAASPTT | 291 | O95343 | |
| DLSPHPLSSSSDGIT | 306 | Q9UIU6 | |
| SSNTSLSGHRGSPSP | 636 | Q8TBC3 | |
| GTSVSPLHPSTTRSS | 186 | Q9Y286 | |
| LTQPPSAHSSITSGS | 416 | Q9HCD6 | |
| LSSSTPGLPSCSTVH | 231 | B1ATL7 | |
| SLKSSSPHSSPGNTV | 346 | O75626 | |
| TASPSLSYSTGHSPA | 526 | Q9ULL5 | |
| LGSVSPSSSGFSSPH | 1111 | Q68CZ2 | |
| PSSSGFSSPHSGSTI | 1116 | Q68CZ2 | |
| TSSTVPISHPAALTS | 91 | Q15319 | |
| SLSSTGSLPSHAPPS | 596 | Q96QB1 | |
| LSSGIATSHSAKPPT | 361 | Q14849 | |
| SGHSSPTSPALSENV | 501 | Q15047 | |
| PGSSSSTYPHSPTSS | 196 | Q15797 | |
| RTPSTTATGHPSLST | 176 | Q96F05 | |
| HIPTALPVSGTLSSS | 571 | Q9Y4G8 | |
| THGTPSAPSRSLSEL | 891 | O94827 | |
| ATITGSESASPVHSP | 981 | Q6GYQ0 | |
| SVSLSHSGSAPDVPA | 51 | Q92610 | |
| SPSGGSTVSFSHTLP | 1421 | Q9HBL0 | |
| LALASTPESSSHTPT | 276 | Q96S82 | |
| GSATTASPAASHPLA | 921 | Q12968 | |
| LTHPVSAPSSSGSPL | 386 | O15178 | |
| HSASGPSSPAVLTVL | 581 | Q9BZZ2 | |
| HPATGTPTTTVDSSA | 26 | O75360 | |
| SLHSPSSASTSPLGS | 471 | Q9H9P5 | |
| GSSTDPLVDHTSPSS | 2661 | P78527 | |
| IQSTPGSGHAPRTSS | 571 | Q9C0B5 | |
| HSPTEVAGTSASSPA | 41 | Q9UIW0 | |
| ASISVRSSTPGSPTH | 201 | Q14CZ0 | |
| RSSTPGSPTHVSSGS | 206 | Q14CZ0 | |
| TSLPRSAHSLQPSSG | 701 | Q96Q05 | |
| LPSASTGIPTASTTS | 606 | Q9H4A3 | |
| HSSRSSTSSLAPGPE | 2121 | Q9Y3S1 | |
| TSLSSTPHASILSVP | 326 | O60806 | |
| HTTPTGSSDPILTTA | 836 | Q9Y334 | |
| PSSLKSRLTGPAHST | 196 | Q7Z2V1 | |
| HVSPSPTGASLQITT | 1166 | Q9H2Y7 | |
| PSHSSSLPLTYGVAS | 96 | Q3YBR2 | |
| SSSTSHLASPPSLGE | 306 | O75385 | |
| ASSELSGPSTPLHTS | 901 | Q63HR2 | |
| PNTHLSSVTTSDLSP | 896 | Q6EMB2 | |
| AEHTATATTPGSTPS | 1081 | Q5T200 | |
| TTTPTRAALSHSGSP | 2906 | Q5THJ4 | |
| PGATGTTLFPSHSAT | 231 | Q9UKN1 | |
| TPSSLGPESTTFHSS | 356 | Q9UKN1 | |
| GSPSSIPTTHISARS | 806 | Q9UKN1 | |
| HSSPGSTDTTLLPAS | 1026 | Q9UKN1 | |
| RSQPGSTHSTVSPAS | 1276 | Q9UKN1 | |
| HSSPGSTDTTLSPGS | 1751 | Q9UKN1 | |
| LGPESTTFHSSPGST | 1771 | Q9UKN1 | |
| GSPHTTLSPAGSTTR | 1811 | Q9UKN1 | |
| SHSSPGSTDTALSPG | 2136 | Q9UKN1 | |
| SSPGSTHTTLFPDST | 2166 | Q9UKN1 | |
| HSTVSPASTTTPGLS | 2366 | Q9UKN1 | |
| THTTAFPDSTTTPGL | 2561 | Q9UKN1 | |
| FPDSTTTPGLSRHST | 2566 | Q9UKN1 | |
| TSHSSPGSTDTTLLP | 2581 | Q9UKN1 | |
| HSSPGSTDTALSPGS | 2611 | Q9UKN1 | |
| SPGSTHTTLFPDSTT | 2641 | Q9UKN1 | |
| VHSSTGSPRTTLSPA | 2666 | Q9UKN1 | |
| TSRSQPGSTHSTVSP | 2831 | Q9UKN1 | |
| ASHSSPGSTDTTLSP | 3306 | Q9UKN1 | |
| LLEASTPVHSSTGSP | 3356 | Q9UKN1 | |
| STGSPHTTLSPAGST | 3366 | Q9UKN1 | |
| HSSPGSTDTTLLPAS | 3666 | Q9UKN1 | |
| RSQPGSTHSTVSPAS | 3916 | Q9UKN1 | |
| HSSPGSTDTTLSPGS | 4391 | Q9UKN1 | |
| LGPESTTFHSSPGST | 4411 | Q9UKN1 | |
| GSPHTTLSPAGSTTR | 4451 | Q9UKN1 | |
| STASHSSPDTNGITP | 4826 | Q9UKN1 | |
| TTPHSQPGSALSTVS | 4966 | Q9UKN1 | |
| FHSSSDATGTTPLPA | 5051 | Q9UKN1 | |
| SGSTLSLNPLPSHSV | 206 | Q86UW6 |